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Low-level laser therapy (LLLT) and cryotherapy are applied to the human skin to 
trigger biological actions in the underlying tissue. LLLT modulates biological 
processes by emitting energy-charged photons to pathological tissue, whereas 
cryotherapy produces its effect on pathology through the reduction of tissue 
temperature. When a treatment leads to an unexpected clinical event, the underlying 
mechanisms involved are often uncertain. This thesis is based upon such a clinical 
observation, and a reversed translational research approach was used to further 
investigate the biophysical and biological effects of combining LLLT and 
cryotherapy in tendinopathy treatment.  
Aim of Thesis 
The overall purpose of this thesis is to investigate the clinical, biophysical, and 
biological effects of LLLT alone and in combination with cryotherapy for the 
treatment of tendinopathy.  
Methods 
This thesis consists of three studies. In Study I, a systematic review with meta-
analysis was performed to determine the effectiveness of LLLT for shoulder 
tendinopathy. A structured search for relevant studies up to May 2013 was executed. 
Two independent assessors rated the included studies according to the Physiotherapy 
Evidence Database (PEDro) scale. Intervention quality assessments were performed 
according to World Association for Laser Therapy (WALT) guidelines. The included 
trials were sub-grouped by intervention quality and the use of other physiotherapy 
interventions. Study II was a basic in-situ research study of repeated measurements. 
The optical energy (from two different Class 3B lasers) penetrating the Achilles area 
of healthy adults was measured before and after 20 minutes of cryotherapy. In Study 
III, a blinded multiple-armed randomized controlled trial (RCT) design with a post 
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intervention test only was used to investigate the biological effects of LLLT and 
cryotherapy, both alone and in combination with each other. The study sample 
comprised in vivo rat Achilles tendons.  
Results  
Optimal LLLT can offer clinically relevant pain relief and initiate a more rapid 
course of improvement, both alone and in combination with physiotherapy 
interventions in patients suffering from shoulder tendinopathy. The systematic review 
identified parallel cryotherapy treatment as a possible confounder to LLLT, as it may 
induce inhibitory effects and negatively influence treatment outcomes. The 
penetration of laser energy increased significantly (p<0.01) through Achilles skin and 
tendons, for both lasers and at all time points, after 20 minutes of cryotherapy. 
Increased LLLT energy penetration occurred when mean skin temperature was 4.8˚C 
(SD±3.6), resulting in a significant reduction in the Achilles tendon (p=0.03) and 
skin-tendon-skin thickness (p=0.05). The biological effect of LLLT (3J) one hour 
after tendon trauma significantly (p<0.05) reduced pro-inflammatory interleukin (IL)-
1ß expression in the presence of the highest median levels of IL-10 (p=0.06) across 
all treatment groups. Cryotherapy alone failed to reach statistical significance over no 
treatment for all the targeted cytokines. The parallel treatment of LLLT and 
cryotherapy produced an anti-inflammatory “add-on” effect and significantly reduced 
the expression of all targeted cytokines except IL-10. Biomechanical and histology 
results suggested that the order of therapy administration was essential, showing 
superior results when LLLT followed cryotherapy.  
Conclusion  
This thesis reveals that the parallel treatment of cryotherapy and LLLT can negatively 
influence the clinical effects of LLLT in shoulder tendinopathy treatment. The optical 
properties of healthy skin and tendons are altered by cryotherapy, which significantly 
increases the penetration of laser energy irradiation. The order of therapy 
administration determined if a positive or negative biological response in injured rat 
Achilles tendons occurred. 
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SD standard deviation 
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1. Introduction 
Translational research is often associated with testing novel ideas in basic laboratory 
studies that aim to produce findings that can be turned into useful clinical 
interventions. However, the path between basic and clinical research is not 
unidirectional but runs both ways. Consequently, returning to the laboratory with 
observations made in human studies can lead to new discoveries, which may increase 
our understanding of human disorders and help us to optimize treatments (Mankoff et 
al., 2004; Littman et al., 2007). Indeed, the evidence for most physiotherapy 
interventions share this clinic-to-basic research history, in which observed clinical 
effects have been explained by plausible biological mechanisms of action in cell and 
animal trials. This thesis follows a similar research strategy, as an unexpected clinical 
observation intrigued and prompted us to gain more insight into the topic of low-level 
laser therapy (LLLT) in combination with cryotherapy for the treatment of 
tendinopathy. 
Tendinopathy is a common and frequently disabling condition that is challenging to 
treat. Physiotherapy treatment options for tendinopathies are manifold, which reflects 
the partly unclear and multifactorial etiology behind the condition (Jarvinen et al., 
2005; Seitz et al., 2011). The effectiveness of exercise-based physiotherapy treatment 
regimens has been extensively studied, and these are currently the cornerstone of 
treatment for tendinopathies. However, the ideal exercise program remains unclear, 
and many patients do not respond positively to exercise alone.  
In physiotherapy, different interventions are often combined to best address the 
individual needs of each patient. However, research studies are often designed to 
measure the effect of these interventions as monotherapies. As most physiotherapy 
interventions have limited potential to cause harm, combining treatment modalities is 
usually a professional decision that is based on clinical reasoning and empiricism. 
Combining LLLT and cryotherapy to reduce pain and accelerate recovery in patients 
with tendinopathy is an example of a treatment combination lacking evidence of 
efficacy and knowledge about biological interactions. 
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Although the use of light and ice as therapeutic modalities share an ancient history, 
light amplification by stimulated emission of radiation (laser) devices first emerged 
as a commercially available option for treating painful musculoskeletal conditions in 
the 1960s (Mester et al., 1968a). Despite initial skepticism regarding its usefulness in 
mainstream medicine, laser therapy research has progressed over the years and 
consistently demonstrates its ability to produce beneficial photobiological effects in 
mammalian cells. However, the transfer of positive results from laboratory research 
to clinical trials on musculoskeletal conditions often produces mixed results. Indeed, 
the first American Food and Drug Administration (FDA) approval of a Class 3B laser 
device that could be marketed for treating musculoskeletal conditions was not issued 
until 2002 (FDA, 2002). In Norway, LLLT treatment was first included in the 
national tariff payment system for physiotherapists in 2001 (Bjordal et al., 2014).  
There have been several studies investigating the efficacy of LLLT for tendinopathy, 
and reviewers were able to identify an optimal laser dose range for treating 
tendinopathy in 2001 (Bjordal et al., 2001). This discovery implies that LLLT trials 
should not be judged by methodological standards only but also by the validity of the 
dose and treatment procedure. Consequently, previously published randomized 
controlled trials (RCTs) and systematic reviews should be examined with new eyes if 
dose and procedural aspects have been left unaddressed. The efficacy of optimal 
LLLT has been synthesized in systematic reviews for some location-specific areas of 
tendinopathy. However, the evidence of effects related to the most prevalent site of 
tendinopathy in the general population, the shoulder, has not yet been reviewed. 
This thesis investigates the clinical, biophysical, and biological effects of LLLT alone 
and in combination with cryotherapy for the treatment of tendinopathy. Chapter 1 is a 
review of relevant literature, which provides the context for the objectives of the 
thesis. The aim of the thesis and included studies are presented in chapter 2. Materials 
and methods are described in chapter 3. The systematic review and meta-analysis 
identifies cryotherapy as a possible confounder to LLLT in tendinopathy treatment, 
and two basic research studies was performed to follow up on this finding. The 
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results from these three studies are found in chapter 4. Finally, the last chapters (5–7) 
provide a discussion, a conclusion, and suggestions for future research.  
1.1 Tendinopathy  
Tendons play a critical role in body mechanics, predominantly by transferring force 
from muscle contraction to bone, thus allowing movement and joint stability. They 
consist of collagen fibrils (primary, secondary, and tertiary fibers), each sheathed by 
an endotenon, which in turn is wrapped in an epitenon. Enclosing the epitenon is a 
third sheath, the paratenon, forming the actual tendon. The microbiology of normal 
tendons is mainly composed of fibroblast-producing cells called tenocytes, which are 
surrounded by an extensive extracellular matrix (ECM). The ground substance of the 
ECM consists of proteoglycans, glycosaminoglycans, glycoproteins, and several 
other small molecules. These components are involved in the development, 
organization, and growth of the tendons. The water-binding proteoglycans enable cell 
migration and the diffusion of molecules. The glycoproteins are active in the repair 
and regeneration of tendon material, while other proteins are important for collagen 
fiber alignment and orientation. This hierarchical and morphological structure gives 
tendons the ability to withstand high unidirectional tensile loads (Sharma and 
Maffulli, 2006; Abate et al., 2009; Magnusson et al., 2010). The mechanical loading 
of tendons is known to have a major influence on ECM turnover, increasing both the 
collagen synthesis and the degrading metalloprotease enzymes (Kjaer, 2004).  
Although tendons are metabolically active tissues dependent on blood supply, 
hypovascular areas have been identified in tendons such as the Achilles and 
supraspinatus (Åstroöm and Westlin, 1994; Mehta et al., 2003). The metabolic rate, 
oxygen consumption, and vascularization of tendons is lower, and the collagen 
turnover time higher, than those of skeletal muscles and other soft tissues (Vailas et 
al., 1978; Sharma and Maffulli, 2005). Consequently, the healing and regeneration 
processes of tendons are considerably slower than those of muscles. 
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Tendinopathy is a term used to describe the multifactorial pathology of non-ruptured 
tendon disorders characterized by localized pain and swelling, a decline in function, 
and a reduced tolerance for loading activities (Maffulli et al., 2003; Wang et al., 
2006; Van Dijk et al., 2011; Magnan et al., 2014a). The origin of the term 
tendinopathy was much influenced by the complex and unclear etiological initiation 
of tendon pain (Maffulli et al., 2003; Rio et al., 2014). Prior to the 1990s, painful 
tendons were referred to as tendinitis, with the -itis ending implying that 
inflammation initiates and drives the condition. New perspectives on tendon disorders 
were published during the next decade, suggesting that the etiology of tendinitis was 
very different from the etiology of other inflammatory conditions. 
The paper entitled “Time to Abandon the Tendinitis Myth,” by Khan et al. (2002), 
had a great impact by strongly proposing that the condition of tendon pain originates 
from a non-inflammatory degenerative process. These non-inflammatory and 
degenerative models dominated thinking on tendinopathy during the first decade of 
the twenty-first century. However, the dogma of degeneration without inflammation 
in tendinopathy has been increasingly challenged in the past 10 years. Development 
in areas such as immunohistochemistry, molecular techniques, and gene expression 
analysis have identified inflammatory reactions in longstanding tendinopathy as well 
as in its early stages (Rees et al., 2013; Millar et al., 2017).  
1.1.1 Risk factors of tendinopathy 
The risk factors of tendinopathy are often characterized as both intrinsic and 
extrinsic, referring to internal tendon processes and external contributing factors. The 
most commonly reported extrinsic risk factor for developing tendinopathy is an 
increased overall volume of tendon loading, often referred to as overuse 
tendinopathy. 
In terms of intrinsic risk factors, advancing age is demonstrated to be among the most 
significant (Maffulli et al., 2003; Seitz et al., 2011; Magnan et al., 2014a). As age 
progresses, the metabolic rate of the tendons decreases, which most likely influences 
reparative ability (Kannus, 2000). In addition, a decrease in the capillary blood 
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supply to the tendon and a degeneration of the tenocytes and collagen fibers are 
typical age-related tendon alterations (Kannus et al., 2005). The tendon loses tensile 
strength, stiffness, and rebound resilience, which may predispose it to injury. 
Degenerative tendon changes due to advancing age can be attenuated by physical 
activity (Narici et al., 2008). However, the optimal loading of the tendon is crucial, as 
the capacity to repair micro-trauma induced by mechanical loading may decrease 
with age (Cook and Purdam, 2009). 
Overuse is not responsible for all tendon pathology. Tendinopathy may also occur 
following external trauma (Wedderkopp et al., 1997, Agel et al., 2007). In addition, 
there are several other factors associated with an increased risk for developing 
tendinopathy, such as anatomical anomalies, genetic factors, muscular insufficiency 
or imbalance, posture, soft-tissue inflexibility, drugs, and various environmental 
conditions (Maffulli et al., 2003; Seitz et al., 2011; Magnan et al., 2014a). 
1.1.2 Tendon healing and regeneration 
Tendons respond to acute injury by initiating several overlapping stages of repair. 
Immediate bleeding and the clotting of blood at the site of the injury characterize the 
hemorrhagic stage of tendon healing. Cytokines and growth factors are released by 
the infiltrated platelets and initiate the inflammatory tendon healing. During this stage 
neutrophils and macrophage phagocytose necrotic tissue, whereas a fibrin clot 
consisting of mainly collagen type 3 is formed by tenocytes to stabilize the injury. 
The increased synthesis of this immature granulation tissue represents the 
proliferative healing phase. The following process of remodeling and maturation is 
characterized by decreased inflammation and increased fibroblast activity, gradually 
replacing the mechanically weaker collagen 3 with the more resilient collagen 1. The 
tendon may remain in this state of fibroblast hypercellularity for up to a year (Wang 
et al., 2006; Voleti et al., 2012; Muller et al., 2013). Nevertheless, the tendon’s 
structural and biomechanical properties may never be completely restored to pre-
injury levels (Oliva et al., 2011; Wang et al., 2012), and many patients develop 
chronic symptoms. 
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It has been proposed that the typical micro-injuries associated with chronic overuse 
tendinopathy may fail to stimulate an adequate inflammatory response and that the 
consequence is a failed healing response by the immune system (Cook et al., 2002; 
Maffulli et al., 2010). Cytokines are frequently investigated inflammatory mediators 
in tendinopathy, much because of their immunoregulatory role and crucial interaction 
with resident tenocytes and ECM (Millar et al., 2017). 
1.2 History of Electrophyscial Agents in Physiotherapy  
“The ability of a clinician to reduce pain in a patient by exploiting the patient’s own 
in-built neurophysiological mechanisms must surely rank as one of the greatest 
achievements of contemporary medical science.” 
 (Woolf, 1984, as cited in Macdonald, 1993) 
The first documentation of physiotherapy as a profession dates back to 1813, when 
the Swede Per Henrik Ling established the Royal Institute of Gymnastics for 
manipulation and exercise in Stockholm (Brodin, 2008). Other countries followed 
this initiative, and by 1920, the Chartered Society of Massage and Medical 
Gymnastics was granted its Royal Charter by King George V in the UK (Chartered 
Society of Massage and Medical Gymnastics, 1929). Physiotherapists were, at this 
point, educated in anatomy and biomechanics and given a license to interact with and 
treat patients using massage and manipulation. The adoption of a biomechanical 
framework and a growing attention to pathology were important for future advances 
in physiotherapy, ultimately leading to the assimilation of new treatment 
interventions in physiotherapy, such as electrotherapy (Nicholls and Cheek, 2006). 
The therapeutic use of electrical stimulation for alleviating pain may originate from 
ancient Greece, where electrical impulses from fish or eels were applied to treat 
painful conditions such as gout and nuclei prolapse. The Greeks termed the electrical 
fish narcs, a precursor to the word narcosis, due to their numbing effect. The ability 
to stimulate or provide shock treatment using mechanically produced static electricity 
emerged during the eighteenth century. These electrical devices were used 
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therapeutically to treat numerous conditions ranging from painful musculoskeletal 
disorders to epilepsy and sterility (Macdonald, 1993). Although the first 
electrotherapy pioneers of this century were convinced of the effect, the medical 
establishment had so far responded with contempt and discredit. Treatment with 
EPAs was first made respectable after Dr. Golding Bird opened an electrical 
department at Guy’s Hospital London in 1836 and gave a series of lectures on 
“Electricity and Galvanism in Relation to Physiology and Therapeutics” at the Royal 
College of Physicians (Selcon, 2001). 
At the beginning of the twentieth century, the first investigative reports and clinical 
trials were published in recognized medical journals. These early papers suggested 
that EPAs should be used as an adjunct therapy to accelerate recovery in 
musculoskeletal conditions, such as peripheral nerve injuries, due to its ability to 
produce contractions in paralyzed muscles (Wolfson, 1931; Doupe et al., 1943). 
Following World War II, more research attention was focused on this phenomenon, 
referred to as galvanic exercises (Tiktinsky et al., 2010). However, the first major 
step forward for treatment with electrical currents was the introduction of the gate 
control theory in 1965, which provided clinicians and researchers with the first 
necessary theoretical framework to explain its pain-relieving effect (Melzack and 
Wall, 1965).  
Over the years, technological improvements and innovations in the field of EPAs 
have been gradually adopted in physiotherapy. New electrophysical treatment 
interventions such as shockwave therapy and LLLT emerged, as well as devices 
suitable for diagnostics and tissue measurements. 
The continued mapping of how EPAs interact with and modulate pathological 
processes in biological tissue, especially in the inflammatory process and tissue 
repair, provided physiotherapists with the necessary tool to possess a more 
autonomous role in the pain management of musculoskeletal disorders. From this 
perspective, new areas of research questions become clear: the effect of adding EPAs 
to other established interventions must be continuously updated; treatment 
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combinations that enhance or reduce the effect of EPAs must be identified; and the 
optimal EPA treatment parameters and timing in relation to different stages of 
musculoskeletal pathology must be determined.  
1.3 Discovery of Low-Level Laser Therapy  
The history of using light for therapeutic purposes goes back more than 3,000 years, 
when people suffering from depigmentation of the skin were exposed to sunlight 
(Fitzpatrick and Pathak, 1959). During the eighteenth century, medical reports 
appeared demonstrated that sunlight could improve and accelerate the healing of 
many different conditions, such as skin ulcers, wounds, and rickets (vitamin D 
deficiency causing bone fragility) (Palm, 1890; Rollier and Rosselet, 1923; Chesney, 
2012; Hamblin and Huang, 2014). Therapeutic exposure to sunlight, known as 
heliotherapy, increased in popularity during the nineteenth century and was 
recommended for several different conditions including depression, rheumatic 
diseases, and scurvy (Cauvin, 1815). 
The first researcher to successfully put artificial ultraviolet (UV) light to medical use 
was Nils Ryberg Finsen (1860–1904). He developed a carbon arc lamp to treat Lupus 
Vulgaris and was honored with the Nobel Prize in Physiology or Medicine in 1903 
for his pioneering work (Grzybowski and Pietrzak, 2012). During the twentieth 
century, the use of both natural and artificial UV light in medicine rose, and 
consequently, much research into the physics of light followed. In the late 1950s, 
Basov and Prokhorov and Townes were able to produce the first laser (Karlsson, 
2000). A decade later, Theodore Maiman developed the first ruby crystal laser, 
operating at a fixed wavelength (694 nanometers [nm]) in the visible red spectrum 
(Maiman, 1960).  
The discovery of LLLT is predominately associated with the pioneering work of 
Hungarian professor Endre Mester (1903–1984). In the 1960s, Mester implanted 
tumor cells beneath the skin in mice. In a failed attempt to destroy these malignant 
tumors with what he believed was a “high power” ruby laser, he instead discovered 
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that the skin incisions healed faster in treated mice. In fact, the custom-made laser 
used in the experiment was actually low powered, and the light accelerated tissue 
repair (Mester et al., 1968a). This observation formed the basis of a new experimental 
study, in which Mester successfully demonstrated faster wound healing in mice 
treated with LLLT (Mester et al., 1971). Inspired by these findings, Mester performed 
several clinical case studies on humans suffering from various chronic unhealed 
wounds and found that the wounds healed in 78% of the treated cases (Mester et al., 
1985). Consequently, the effects of LLLT in biological tissue were referred to as 
photobiostimulation. However, the therapeutic application of LLLT extended beyond 
wound healing, and later research demonstrated that LLLT produced beneficial 
inhibitory effects in other conditions. It is now agreed that the term 
photobiomodulation therapy (PBMT) more accurately describes the mechanism by 
which low level lasers work in biological tissue. 
1.3.1 Components and characteristics of LLLT irradiation 
To produce laser light, three basic components are needed: a lasing medium, a power 
source, and a resonating cavity. Reflective mirrors, lenses, and other mechanical 
structures are added to manipulate the power output, irradiation mode (continuous or 
pulsed waves), and beam shape. The atoms or molecules from the lasing media are 
excited to higher energy levels by the power source, which generates photons of light 
(i.e., the emission of radiation). The lasing medium can be gaseous, liquid, solid 
crystal, or semiconductor. This component dictates the wavelength (nm) and the color 
of the light emitted from the machine (Baxter and Diamantopoulos, 1994). 
Laser light is characterized by being monochromatic (single-colored) and of a defined 
wavelength. Because these waves of light travel in a synchronized phase, it is 
described as being highly coherent. The divergence of the laser beam is small and can 
be focused on a tiny area, which is referred to as collimation. Some devices also 
produce polarized light, meaning the waves of light are oriented in one plane only 
(Baxter and Diamantopoulos, 1994; de Freitas and Simoes, 2015). The biological and 
clinical relevance of coherence and polarization is not clear. 
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1.3.2 LLLT parameters  
Lasers used for the treatment of musculoskeletal conditions are classified as 3B. 
These lasers typically have a wavelength ranging from 632 to 904 nm and a mean 
output power (MOP) between 5 and 500 milliwatts (mW). The energy absorption in 
water, cutaneous melanin, and hemoglobin differs with certain wavelengths but is 
lowest in the red and near-infrared spectrum (600–1000 nm) (Anderson and Parrish, 
1981; Karu and Kolyakov, 2005). Infrared lasers (780–1000 nm) penetrate skin with 
less energy attenuation than red wavelength lasers do (600–700 nm) (Anderson and 
Parrish, 1981; Stolik et al., 2000). Thus, wavelength is an important parameter to 
consider if the targeted tissue is deeply situated. 
Laser devices can deliver energy either continuously or in a pulsed mode. In 
continuous wave (CW) mode, the emitted energy (power output) over time is 
constant, whereas in pulsed mode, the energy may be delivered with high pulse peak 
powers and pauses. These pauses reduce the MOP of the laser, allowing it to still be 
classified as 3B even if the pulse peak power exceeds the 500 mW limit. 
The therapeutic energy dose in LLLT is delivered in joules (J) and is calculated as the 
average power output emitted in watts (W) multiplied by seconds (s) of irradiation in 
a point. Energy dose is also reported as power density (mW/cm2), which is defined by 
the power output divided by the laser beam spot size (cm2) at the tissue surface. 
However, the validity of spot size measurements is debatable, as the distribution of 
power is not uniform across the laser beam (Baxter and Diamantopoulos, 1994; 
Nussbaum et al., 2003). Energy density is another parameter reported in LLLT 
literature and reflects the amount of energy (J/cm2) received by the irradiated tissue. 
Energy density is calculated by adding time (s) to the equation of power density.  
However, it has been argued that LLLT doses expressed in J/cm2 are inadequate, as 
the calculations are based on the beam spot size, for which there is no agreement 
about how to define (Jenkins and Carroll, 2011). To overcome this shortcoming, 
Nussbaum et al. (2003) suggest that energy (J) per irradiated point should replace 
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power density and that the total energy of the treatment (J) should replace energy 
density. 
1.3.3 LLLT penetration 
The laser must penetrate the skin barrier with a sufficient amount of energy to 
modulate pathophysiological processes in musculoskeletal conditions. Wavelength is 
the main determiner regarding the penetration depth of a laser device. Lasers with 
longer wavelengths can penetrate tissue deeper than lasers with a shorter wavelength 
are able to. Furthermore, light energy can be “lost” before reaching deeper-situated 
pathology due to photon absorption and scattering in non-targeted tissue, and 
reflection of the skin surface (Bashkatov et al., 2011). The most commonly 
researched and clinically used wavelengths in LLLT are 632.8 nm helium-neon 
(HeNe), 810–830 nm gallium-aluminum-arsenide (GaAIAs), and 904 nm gallium 
arsenide (GaAs) (Enwemeka, 2000; Karu et al., 2001). The light penetration increases 
almost linearly with increasing wavelengths (450–1030 nm) in human skin samples 
(Ackermann et al., 2002). Red light lasers (600–700 nm) are easily absorbed by 
hemoglobin and melanin and penetrate approximately 4–5 mm into the skin (Ash et 
al., 2017). However, due to the circular-shaped scattering of red light, the indirect 
penetration depth should be deeper (de Freitas and Simoes, 2015). There is an 
“optical window” around 810 nm, where light can penetrate several centimeters (cm) 
into the tissue (Henderson and Morries, 2015; Hamblin, 2016). The elliptic-shaped 
scattering of infrared wavelengths can increase the indirect penetration even more 
(Mcleod, 2004; de Freitas and Simoes, 2015).  
Although penetration depth in biological tissue is predominantly dependent upon 
wavelength, photons of light are more easily transmitted if the emitting diode is 
pressed firmly in contact with the skin. Conversely, the application of LLLT in non-
contact mode will increase reflection and reduce the penetration of photons through 
the skin (de Freitas and Simoes, 2015). 
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1.3.4 Biophysical effects of LLLT treatment 
The exact biochemical mechanisms responsible for the therapeutic effects of LLLT 
are not yet well established. It is suggested that the underlying mechanisms of action 
could be manifold, including molecular, cellular, and tissular responses. There is 
consensus that the effects of LLLT treatment occur according to the first law of 
photobiology, which states that for low-power light to have any effect on a living 
biological system, the photons must be absorbed by some molecular photoacceptors 
or chromophores. The construction of an action spectrum (i.e., a plot of biological 
effects against wavelength) supports the existence of cellular photoacceptors and 
signaling pathways stimulated by light (Huang et al., 2011; Chung et al., 2012).  
The principal photoacceptors for monochromatic red and near-infrared light in 
mammalian cells have been attributed to the cellular respiratory chain, and the protein 
complex cytochrome c oxidase (CCO) located in the inner mitochondrial membrane 
(Karu, 1989; Karu and Afanas’eva, 1995). The application of LLLT to mitochondria 
increases the proton electrochemical potential, which results in increased adenosine 
triphosphate (ATP) production and electron transport. The activity of CCO is 
inhibited by nitric oxide (NO), which down-regulates cellular respiration (Fig. 1). It 
has been observed that LLLT releases NO from CCO, thereby preventing this process 
from occurring and promoting an increased cellular respiration rate (Karu et al., 2005; 
Moriyama et al., 2005). 
Figure 1. Schematic illustration of photon absorption by chromophores in the cell mitochondria and 
the release of NO, which is inhibiting CCO. Adapted from Huang et al. (2011). 
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Another possible mechanism of action for LLLT is an increased production of 
reactive oxygen species (ROS). ROS are natural by-products of cell oxidation and are 
involved in the signaling pathways from mitochondria to nuclei. Increased oxidation 
and expressions of ROS have been demonstrated after LLLT irradiation, which may 
influence the cellular redox state and induce several transcriptional changes. This 
cascade of cellular events triggers additional effects, such as increased cell 
proliferation and migration, a modulation of inflammatory mediators and growth 
factors, and increased tissue oxygenation (Huang et al., 2011; Chung et al., 2012; de 
Freitas and Hamblin, 2016). 
An imbalance in the cellular redox state with high levels of ROS is seen in several 
soft tissue lesions; this is often referred to as oxidative stress (Ribeiro et al., 2016). 
The potential harmful effects of increased ROS on the healing process are controlled 
by cellular anti-oxidant enzymes such as superoxide dismutase (SOD), catalase 
(CAT), and glutathione peroxidase (GPx) (Barbieri and Sestili, 2012). LLLT has 
demonstrated a reduction of ROS in oxidatively stressed cells (Huang et al., 2013) 
and the attenuation of oxidative stress in several pathological lesions, such as 
arthritis, muscle injuries, and tendinopathy (Fillipin et al., 2005; dos Santos et al., 
2017b; dos Santos et al., 2017a; De Marchi et al., 2017). Although the exact 
mechanisms are yet to be fully understood, LLLT seem to up-regulate the anti-
oxidant defenses, reduce oxidative stress after injury, and increase ROS production in 
normal viable cells (Hamblin, 2017). 
1.3.5 The effect of LLLT in tendinopathy treatment  
When tendons are injured or traumatized, several biochemical mediators are released 
into the tissue. These include alterations in cytokine gene expression and 
metalloproteinase (MMP), increased levels of cyclooxygenase-1(COX-1) and 
cyclooxegynase-2 (COX-2), and, consequently, increased levels of inflammatory 
chemicals such as substance P and prostaglandins (Rees et al., 2013). 
The anti-inflammatory effect of LLLT in tendinopathy has been extensively 
investigated over the years, and its ability to alter cytokine gene expression, COX-1, 
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COX-2, and the expression of inflammatory mediators have been demonstrated in 
several animal trials (Marcos et al., 2011; Marcos et al., 2012; Casalechi et al., 2013; 
de Jesus et al., 2015; Torres-Silva et al., 2015). There is some evidence that the anti-
inflammatory effect of LLLT can be translated to humans, as reduced prostaglandin 
E2 (PGE2) levels have been measured by microdialysis in Achilles tendinopathy 
patients treated with LLLT (Bjordal et al., 2006b). LLLT has also demonstrated 
beneficial effects in the tendon repair process (Oliveira et al., 2009; Marcos et al., 
2014), possibly by increasing collagen synthesis (Reddy et al., 1998), downregulating 
catabolic metalloproteinase enzymes (Marcos et al., 2014), regulating oxidative stress 
(Fillipin et al., 2005), and suppressing cell apoptosis (Sussai et al., 2010; Chen et al., 
2011). 
LLLT is used clinically to alleviate pain and accelerate recovery in tendinopathy. 
Although there is uncertainty about how to transfer consistent results from laboratory 
settings to clinical trials (Basford, 2005), the effect of LLLT appears to depend 
largely on the use of optimal laser doses. Systematic reviewers have identified such a 
dose-dependent effect of LLLT in lateral elbow (Bjordal et al., 2008) and generic 
tendinopathies (Tumilty et al., 2010), as well as in chronic joint disorders (Jang and 
Lee, 2012), neck pain (Chow et al., 2009), and osteoarthritis of the knee (Bjordal et 
al., 2007). 
1.4 Cryotherapy 
The history of medical cryotherapy dates back to 3000 BC, when ancient Egyptians 
used cold compresses to alleviate pain and reduce inflammation. The Greek physician 
Hippocrates advocated for the therapeutic use of cold to control hemorrhages and 
reduce the swelling of painful joints as early as 500 BC. Local application of cold for 
anesthetic purposes was described by monks in the mid-eleventh century (Grattan and 
Singer, 1952; Korpan, 2007). During the Napoleonic wars, Napoleon’s surgeon, 
Dominique-Jean Larrey (1776–1842), used the vasoconstrictor and numbing effect of 
local cryotherapy to facilitate amputations (Larrey and Mercer, 1832). In the period 
of 1845 to 1851, Dr. James Arnott (1797–1883) focused much of his work on the use 
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of cold in anesthesia. He initially used cold to treat malignant disease and observed 
that even though this did not cure the patients, morbidity and pain were considerably 
reduced (Arnott, 1851; Bird, 1949; Korpan, 2007). The cooling of wounds to reduce 
local inflammation and pus formation was strongly recommended by German 
military surgeon Johan Friedrich August von Esmarch around the same time 
(Esmarch, 1865). His great passion for cryotherapy in emergency care led him to gain 
the nickname “Fritz the ice pack” (Beyer and Dick, 2001).  
During the twentieth century, the application of ice packs and other local cryotherapy 
modalities became a widespread first aid treatment for acute soft-tissue injuries, in 
both domestic and sports medicine (Bierman, 1955; Blonstein, 1966). Physician Gabe 
Mirkin later suggested that first aid treatment for acute musculoskeletal injuries 
should be expanded to include four elements: rest, ice, compression, and elevation 
(resulting in the acronym RICE) (Mirkin, 1978). The RICE guidelines were quickly 
recognized by healthcare practitioners and implemented as the gold standard for the 
management of acute sports injuries (Wallace et al., 1979; Renström and Johnson, 
1985), despite the discrepancy between the alleged therapeutic mechanisms and 
clinical effects (Swenson et al., 1996). The management of acute soft tissue injuries 
was later expanded to include the element of protection, and the acronym RICE was 
replaced by PRICE. Recently, Bleakley et al. (2011) suggested that the guidelines for 
the management of acute injuries should also reflect strategies for ensuring early 
optimal loading. Hence, a new acronym, POLICE (which represents protection, 
optimal loading, ice, compression, and elevation) was recommended to guide 
management. 
1.4.1 Therapeutic mechanisms of cryotherapy  
Cryotherapy can be defined as the application of any physical medium to the body 
that removes heat and decreases the temperature of the contact area and adjacent 
tissue (Nadler et al., 2004). The reduction in tissue temperature is regarded as the 
main trigger for any biophysical effect of cryotherapy. 
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These effects can be categorized as follows: 
• Attenuation of inflammatory response (vascular changes) 
• Effects on metabolism (reducing the sequela of injuries) 
• Effects on nerve conduction (cold-induced neuropraxia)  
Attenuation of inflammatory response (vascular changes)  
The rationale for using cryotherapy in acute soft-tissue injuries is a general 
attenuation of the inflammatory process. Decreasing the temperature of the skin and 
underlying soft tissue reduces blood flow by causing a sympathetic vasoconstrictor 
reflex of the smooth muscle component on the vessel wall (Ho et al., 1994; Knobloch 
et al., 2007; Gregson et al., 2011). The cold-induced vasoconstrictor response and 
subsequent reduction in blood vessel diameter can help to reduce the amount of 
edema (Sloan et al., 1989; Deal et al., 2002; Schaser et al., 2007), which contains a 
large number of inflammatory cells. 
However, we also suggest that the main possible mechanism to reduce edema is the 
decrease of biochemical activity at the inflammatory site, especially the enzymatic 
activity that cools down dramatically with the reduction of temperature. This 
hypothesis from our group make sense because increases in vascular permeability, 
which is the main phenomenon of edema, is not physiologically related to 
vasodilation (Claesson-Welsh, 2015). The leukocyte migration through the 
endothelial cells following soft-tissue injuries is allowed because of the increased 
vascular permeability (Menger et al., 1992; Vestweber et al., 2014). It has been 
demonstrated that cryotherapy reduces the amount of rolling and adhering leukocytes 
on the endothelium after muscle contusion injuries in rats (Menth-Chiari et al., 1999), 
which can also help to control the inflammatory process and edema. It is also argued 
that the increased viscosity of cooled blood increases blood flow resistance, which 
further contributes to reduced local circulation and decreased permeability of the 
blood vessels (McMaster, 1977; Swenson et al., 1996). A decrease in edema 
formation also puts the injured tissue under less mechanical tension, which together 
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with reduced stimulation of sensory nerve endings could have a pain-reliving effect 
(Hocutt Jr., 1981). 
Although tendinopathy is a common musculoskeletal condition in both the general 
population and in sports medicine, the mechanism of effect and clinical benefit of 
cryotherapy for this condition are unclear. At present, very few studies have 
investigated the vascular and cellular effects of cryotherapy for tendinopathy. 
However, a significant decrease in capillary blood flow has been reported after local 
cryotherapy was performed on healthy human Achilles tendons (Knobloch et al., 
2007). A reduced expression of COX-2 and the inflammatory mediator PGE2 have 
also been demonstrated following local cryotherapy in acute mouse patellar and 
Achilles tendinopathy (Zhang et al., 2014). These findings have not been translated to 
human tendinopathy but could be explained by the temperature-sensitive expression 
of PGE2. Synovial PGE2 concentration decreased and correlated well with knee joint 
temperature in humans after postoperative cryotherapy (Stålman et al., 2011). 
However, evidence for a beneficial anti-inflammatory effect of cryotherapy is 
somewhat conflicting. A single study using 20 minutes of local cryotherapy showed 
no effect on inflammatory cytokine expression in rats subjected to acute skeletal 
muscle injury (de Almeida et al., 2014). On the contrary, Schaser et al. (2007) 
demonstrated that six hours of percutaneous cooling following a crush injury to 
skeletal muscle in rats significantly reduced the number of leukocytes, granulocytes, 
and macrophages in the injured area. Another animal study suggested that local 
cryotherapy immediately after muscle injury could be harmful and significantly delay 
the regeneration process, despite decreasing inflammation. Twenty minutes of local 
cryotherapy following a crush injury to skeletal muscle in rats slowed the migration 
of macrophages and, thereby, the secretion of growth factors to the injured area 
(Takagi et al., 2011). In contrast, Ramos et al. (2016) found that intermittent 
cryotherapy (three 30-minute sessions, every two hours) during the first 48 hours 
after muscle injury in rats decreased macrophage invasion and inflammatory markers, 
without having a negative influence on the regeneration process. 
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Effects on metabolism 
Cryotherapy is also used for reducing the metabolic rate of injured soft tissue. 
Following injury, cellular damage is directly caused by the trauma, but adjacent tissue 
areas may also suffer oxidative stress due to trauma-induced vascular disruption. A 
lack of oxygen hampers normal cellular processes and may lead to apoptosis and the 
release of more inflammatory mediators and edema (Rock and Kono, 2008). This 
process is referred to as secondary hypoxic injury. It is proposed that the slowing of 
cell metabolism by cryotherapy reduces the rate of oxygen consumption, and 
therefore has a protective effect on injured tissue. Evidence for such an effect on cell 
metabolism by cryotherapy has been demonstrated in rat muscle subjected to crush 
injuries and in humans suffering from acute traumatic injury to large joints (Ho et al., 
1994; Merrick et al., 1999; Siqueira et al., 2016). Siqueira et al. (2016) found that 
intermittent cryotherapy (three 30-minute sessions of local cryotherapy) reduced ROS 
and oxidative stress in rat muscles subjected to crush injuries. Similar findings were 
reported after four hours of continuous icing, by Merrick et al. (1999). Ho et al. 
(1994) demonstrated that 20 minutes of local cryotherapy to human knees decreased 
arterial and soft-tissue blood flow as well as bone uptake, which can be explained by 
reductions in cell metabolism. It has also been demonstrated that cryotherapy reduces 
skeletal muscle damage in ischemic and reperfused muscle in rats, which could be 
attributed to a reduction in oxidative stress and inflammation (Mowlavi et al., 2003; 
Puntel et al., 2013). 
Effects on nerves 
The external cooling of tissue is well known for inducing an analgesic effect on 
peripheral nerves. The activation threshold of nociceptors situated in soft tissue 
decreases after cryotherapy, and the conduction velocity of pain signals slows down 
(Mc et al., 1984; Algafly and George, 2007; Herrera et al., 2010). The relationship 
between peripheral nerve conduction velocity and temperature was found to be 
roughly linear in a study of the saphenous nerve in cats (Franz and Iggo, 1968). 
Prolonged cooling and very low temperatures have been shown to cause transient 
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injury to peripheral nerves in humans (Bassett et al., 1992; Moeller et al., 1997). The 
threshold for inducing optimal cryoanalgesia in a clinical setting seems to occur at 
skin temperatures between 10 and 13˚C (Bugaj, 1975; Algafly and George, 2007).  
1.4.2 Clinical effects of cryotherapy  
To the best of our knowledge, no rigorous clinical trials investigating the effects of 
cryotherapy in human tendinopathy have been published. Only one basic research 
study has examined the potential anti-inflammatory effect of cryotherapy in 
tendinopathy (Zhang et al., 2014). There are numerous animal studies demonstrating 
beneficial biophysical effects of cryotherapy in other soft-tissue lesions such as 
muscle injuries (Hurme et al., 1993; Merrick et al., 1999; Menth-Chiari et al., 1999; 
Schaser et al., 2007; Puntel et al., 2013; Siqueira et al., 2016), but translational 
clinical studies demonstrating efficacy in humans are lacking (Bleakley et al., 2012).  
In a systematic review including 22 RCTs, Bleakley et al. (2004) assessed the 
evidence in favor of using cryotherapy to manage a variety of acute soft-tissue 
injuries. The authors conclude that more high-quality trials are needed to provide 
evidence-based guidelines for the management of acute soft-tissue injuries. Similar 
conclusions were reported in a systematic review investigating the clinical 
effectiveness of RICE therapy in acute ankle sprains (van den Bekerom et al., 2012). 
The effect of cryotherapy in the acute phase post ACL surgery was assessed in 
another systematic review and demonstrated a significant effect on pain but no effects 
on functional outcomes (Raynor et al., 2005). In contrast, no effect on post-operative 
pain or function was found in a systematic review investigating the effect of 
cryotherapy after total knee arthroplasty (Adie et al., 2010).  
There is a lack of scientific consensus regarding important treatment parameters such 
as the optimal application method, duration, frequency, and timing of cryotherapy 
(MacAuley, 2001). Consequently, there is considerable heterogeneity in treatment 
procedures across studies investigating the efficacy of cryotherapy, both in humans 
and animals. In addition, the majority of clinical cryotherapy trials investigating its 
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efficacy in soft-tissue lesions are of poor methodological quality (Bleakley et al., 





The overall objective of this thesis was to investigate the clinical, biophysical, and 
biological effects of LLLT and cryotherapy for the treatment of tendinopathy.  
Study I 
The aim of Study I was to review literature for patients with shoulder tendinopathy to 
examine the effect of LLLT as monotherapy and the potential benefit of adding 
LLLT to exercises or a multimodal physiotherapy treatment regimen, including its 
effect magnitude compared with other electrophysical agents. 
Study II 
The aim of Study II was to investigate energy penetration from two therapeutic 
infrared lasers through skin and the Achilles tendon in healthy participants, before 
and after 20 minutes of cryotherapy. 
H0: Laser optical energy penetration through the Achilles tendon area does not 
change after 20 mins of cryotherapy. 
H1: There are changes in laser optical energy penetration through the Achilles tendon 
area after 20 mins of cryotherapy. 
Study III 
The aim of Study III was to investigate the anti-inflammatory and biomechanical 
effects of LLLT and cryotherapy as monotherapies and in combination with each 
other, one hour after acute Achilles tendon trauma in rats. 
H0: A single dose of cryotherapy followed by LLLT, or LLLT followed by 
cryotherapy, is no more effective on tensile strength and cytokine expression than no 
treatment, LLLT alone, or cryotherapy alone.  
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H1: A single dose of cryotherapy followed by LLLT, or LLLT followed by 
cryotherapy, is more effective on tensile strength and cytokine expression than no 
treatment, LLLT alone, or cryotherapy alone.  
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3. Material and methods  
3.1 Design  
3.1.1 Study I  
This study is a systematic review and meta-analyses of RCTs.  
3.1.2 Study II  
This study is a basic research study on in-situ human tissue. The study has a single 
factor experimental design and includes repeated measurements. 
3.1.3 Study III 
This study is a blinded RCT on LLLT and cryotherapy in in vivo rat Achilles 
tendons. The study has a post intervention test only, control group design. 
3.2 Materials (subjects) 
3.2.1 Study I 
The systematic literature search identified a total of 395 potentially relevant trials. 
Two independent reviewers assessed these papers for suitability for inclusion. Only 
RCTs, controlled clinical trials, or trials with crossover design including human 
participants diagnosed with shoulder tendinopathy or subacromial impingement 
syndrome (SAIS) were eligible for inclusion. One group in the controlled trial had to 
be treated with LLLT (Class 3B) with reported outcome measures for pain or global 
improvement. Any disagreement regarding trial eligibility was resolved in consensus 
meetings between the reviewers. The final study population comprised 17 RCTs and 
854 shoulder tendinopathy patients. The flowchart (Fig. 2) displays the results of the 




Figure 2. Flowchart illustrating the inclusion process 
3.2.2 Study II 
This study sample consisted of 54 healthy human Achilles tendons. Twenty-seven 
students from Bergen University College (20 women and 7 men), of light skin color 
and with ages ranging from 20 to 30 years, volunteered to participate in the study. 
Both the right and left Achilles tendons of the participants were included in the study 
sample. 
3.2.3 Study III 
This study was performed using 36 male Wistar rats weighing 200–250 g. The rats 
received food and water ad libitum. The rats were randomly divided into six groups, 
with six animals in each group: 
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1. Healthy control group (HCG)  
2. Injured non-treated control group (ING) 
3. LLLT group (LG) 
4. Cryotherapy group (CG)  
5. LLLT first/cryotherapy group (LCG) 
6. Cryotherapy first/LLLT group (CLG)  
3.3 Data collection (procedures)  
3.3.1 Study I 
A systematic literature search for clinical RCTs was performed on May 14, 2013 on 
Medline, PubMed, Embase, the Cumulative Index to Nursing and Allied Health 
Literature (CINAHL), the Physiotherapy Evidence Database (PEDro), and the 
Cochrane Controlled Trial Register Database. It is claimed that consulting Medline 
and Embase ensures a comprehensive literature search due to the minimal overlap 
between databases (Minozzi et al., 2000). However, we also applied the search 
strategy recommended by van Tulder et al. (2003). The keywords used were as 
follows: (low level laser therapy OR low intensity laser therapy OR low energy laser 
therapy OR phototherapy OR HeNe laser OR IR laser OR GaAIAs OR GaAs OR 
diode laser OR NdYag) AND (tendonitis OR tendinitis OR tendinopathy OR 
subacromial impingement OR impingement syndrome OR shoulder tendonitis OR 
shoulder tendinitis OR rotator cuff tendonitis OR rotator cuff tendinitis OR 
supraspinatus tendonitis OR supraspinatus tendinitis). Researchers in the field were 
contacted and contributed additional information. Article references were screened 
for potentially relevant trials. Unpublished material and abstracts were not included. 
No language restrictions were imposed. 
Studies were subsequently categorized according to control group measures to answer 
these four core questions: 
I. Does LLLT work in shoulder tendinopathy patients? 
- Control group receiving placebo LLLT or no therapy  
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II. Does LLLT work in combination with exercise?  
- Control group receiving exercise and placebo LLLT  
III. Does LLLT work in combination with several physiotherapy interventions? 
- Control group receiving a combination of exercises and other 
modalities 
IV. Does LLLT work better than other EPAs? 
- Control group receiving other EPAs 
Two reviewers independently assessed the methodological quality of the included 
trials against the 10-point PEDro checklist (Maher et al., 2003), as exaggerated effect 
sizes have been reported for trials with weaker methodologies (Schulz et al., 1995). 
Disagreement regarding the rating of individual items between reviewers was 
resolved by consensus. Trials were labeled as “high,” “moderate,” or “poor,” 
according to the total attainable sum score. The 17 included RCTs were also 
subjected to an in-depth assessment of possible confounders related to LLLT 
treatment parameters and procedures. Trials not adhering to the current treatment 
recommendations issued by the World Association for Laser Therapy (WALT) were 
classified as having “inadequate dosage.”  
3.3.2 Study II 
The room temperature was recorded before each experiment began. The participants 
were placed in a prone position, lying on a bench, with both ankles placed off the end 
of the bench, leaving the ankle joint in a neutral position. The experiment was carried 
out in eight steps. The MOP of each laser device was recorded for 3 s before and after 
each irradiation. Lasers in the order of 810 nm and 904 nm wavelengths were applied, 
changing every second time. Following is a list of the eight steps: 
1. A pen mark was drawn on both Achilles tendons, 2.5 cm proximal to the superior 
ridge of the Os calcaneus.  
2. The Achilles area was ultrasonographically scanned in both the longitudinal and 
transverse planes, and one image in each plane was saved for further processing. The 
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longitudinal image covered the superior tip of the Os calcaneus and the distal third of 
the Achilles tendon. The transverse image was obtained with the probe covering the 
pre-drawn pen mark on the Achilles. 
3. A thermographic camera was placed approximately 50 cm over the subject’s 
ankles, covering both Achilles tendons, and one image was recorded.  
4. Laser irradiation was performed with the subject lying on their side and the Os 
calcaneus placed on a mobilization wedge. The laser probe was placed in a tripod and 
pressed firmly to the medial side of the Achilles tendon (2.5 cm proximal to the Os 
calcaneus). A handheld optical power meter (OPM) was pressed firmly against the 
lateral side of the Achilles at the same level. The amount of energy penetrating 
through the skin and tendinous tissue was recorded after 1 s, 30 s, 60 s, 90 s, and 
120 s irradiation by the 904 nm laser, and after 1 s, 30 s, and 60 s irradiation by the 
810 nm laser. 
5. The subject was lying prone during 20 mins of tissue cooling. An icepack 
containing 28 icecubes was applied directly over each Achilles area, covering the 
targeted distal third of the tendon. The subject was not allowed to change body 
position to ensure an equal and comparable cooling effect. 
6. The icepacks were removed after 20 minutes, and a post-cooling thermographic 
image was recorded (per step 3). 
7. The subject was again positioned on their side, and the post-cooling LLLT 
procedure was performed (per step 4). While measuring laser energy penetration on 
one Achilles, the other Achilles was kept cool. 
8. The Achilles areas were scanned with real-time ultrasonography (RTUS) (per step 
2). While scanning one Achilles, the other Achilles was kept cooled.  
After all the participants had completed the procedures, the RTUS images were 
scored. The built-in caliper of the US device was used to measure the tissue size. In 
the longitudinal images, tendon thickness in an anterior-posterior (A-P) direction was 
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measured at 2.5 cm proximal from the tip of the Os calcaneus. In transversal images, 
tissue was measured 0.4 cm profound from the dorsal skin surface overlaying the 
Achilles. Tendon thickness was measured as the distance within the medial-lateral 
(M-L) border of the peritenon, and the total amount of tissue the laser irradiation 
should penetrate was measured as the skin-to-skin M-L distance. 
3.3.3 Study III 
The rats were anesthetized with ketamine/xylazine (100 and 20 mg kg−1, 
respectively), and individually positioned with the right hind limb and knee extended 
and the ankle in 90° dorsiflexion. Then, a mini-guillotine consisting of a block 
weighing 200 grams (g), with a blunt edge 2 mm wide was dropped from 20 cm, with 
guided support, to induce injury to the Achilles tendon. Previous studies have shown 
that the mini-guillotine model produces acute inflammation and the degradation of 
tendon collagen (Oliveira et al., 2009; Joensen et al., 2012). After 24 hours, the 
animals were euthanized with an overdose of halothane for biomechanical, 
histological, and biochemical analyses. The skin and connective tissue was removed 
in order to harvest the Achilles tendons for further analyses. A sample of six tendons 
per group were available for analyses of cytokine expression. Four tendons were used 
for the biomechanical procedure, and the remaining two tendons were used for 
histology examinations. All procedures were performed by one observer. To ensure 
consistency in the analyses and the reproducibility of the histology and cytokine 
results, a second laboratory duplicated the blinded analyses, and any disagreement 
was resolved by consensus-based discussions. 
Histology procedure 
The tendon tissue samples were fixed in a 10% formalin solution (Formaldeído PA, 
Synth, Diadema, São Paulo, Brazil) for 72 hours. The samples were then dehydrated 
in a series of alcohol baths (Alcohol PA, Synth, Diadema, São Paulo, Brazil), 
beginning with 50% and progressing to 100%. The samples were cleared in xylol 
(Xilol PA, Synth, Diadema, São Paulo, Brazil) for four hours and embedded in 
Paraplast® (Tyco, Mansfield, MA, USA) for four hours for impregnation. Slices 5 
 40 
micrometers (µm) in thickness were cut, stained with hematoxylin and eosin, and 
mounted on glass slides for histological evaluation. 
Cytokine procedure 
Interleukin (IL)-1β, IL-6, and IL-10, and tumor necrosis factor alpha (TNF-a), levels 
in the tendon samples were determined by enzyme-linked immunosorbent assay 
(ELISA) (R&D Systems, Minneapolis, MN, USA) according to the manufacturer’s 
instructions. For this purpose, 96-well plates (R&D Systems, Minneapolis, MN, 
USA) were coated with 100 microliters (µL) of monoclonal antibody for each 
cytokine (anti-IL-1β, IL-6, and IL-10) and diluted in sodium carbonate buffer (Sigma, 
Aldrich, Brazil) (0.1 M, pH 9.6); anti-TNF-α was diluted in sodium phosphate buffer 
(0.2 M, pH 6.5). The plates were incubated (4°C) for 18 hours. For blocking, the 
plates were washed with phosphate-buffered saline containing 0.05% Tween 20 
(PBST) four times, and then filled with 300 L/well of blocking solution (3% gelatin 
in PBST; Sigma, St. Louis, MO, USA) at 37°C for three hours and subjected to a new 
cycle of washes. Next, 100 µL of properly diluted samples or standards of 
recombinant cytokines were added to the plate and left for 18 hours at 4°C. After 
washing, 100 µL of the respective biotinylated antibodies for the specific detection of 
each cytokine was added and left for one hour at room temperature. After the plates 
were washed, 100 µL of streptavidin-peroxidase was added and left for one hour at 
room temperature (22°C), followed by further washing. The reaction was revealed by 
adding 100 µL/well solution of 3,3’, 5,5’-tetramethylbenzidine and stopped by adding 
50 µL/well of sulfuric acid (2 Molar [M]). 
Biomechanical procedure 
Testing was performed immediately after tendon removal to avoid the influence of 
incubation (Screen et al., 2006). The mechanical characteristics were extracted from 
the force-displacement curves obtained from cyclic loading at a constant velocity of 1 
millimeter per minute (mm/min) for each tendon (Marcos et al., 2014). At each cycle, 
tendon displacement was increased by 10% and force was released until 0.1 Newton 
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(N) was reached. The sequence was repeated until complete tendon failure was 
achieved. 
3.4 Intervention (treatment)  
3.4.1 Study I 
Participants were treated with Class 3B lasers in the infrared spectrum with 
wavelengths ranging from 830 nm to 1064 nm. The mean treatment duration across 
the 17 included trials was three weeks. A total of 12 out of 17 trials used a direct laser 
application technique targeting the tendon pathology. In one study, a non-direct scan 
technique was used. The remaining four studies did not report the mode of LLLT 
application. Energy dose per irradiated point ranged from 0.72 to 4.5 J, and the total 
number of irradiated points ranged from 1 to 10 J. 
3.4.2 Study II  
Two commercially available infrared Class 3B lasers were used for irradiation of the 
Achilles tendons. The 810 nm-wavelength laser (Thor LX2, Thor UK) operates in 
CW mode with a 200mW MOP, a spot size of 0.0314 cm2, and a power density of 
6.37 W/cm2 (manufacturer’s specifications). The 904 nm-wavelength laser (MID-
laser, Irradia Sweden) operates in a super pulse wave (SPW) mode with a peak power 
of 20W, pulse train frequency of 6 kilohertz (kHz), pulses at 100 nanoseconds (nsec) 
(10-9 sec), a width of 30.000 pulses per s, a 60 mW MOP, a spot size of 0.0364 cm2, 
and a power density of 1.67 W/cm2 (manufacturer’s specifications). 
The left and right Achilles tendon of each subject was irradiated before and after 20 
minutes of ice application. Tendons were irradiated for a total of 60 s with the 810 
nm laser and 120 s with the 904 nm laser (Table 1). Domestic ice cube bags 
containing 28 ice cubes per bag were produced in a freezer at -10°C and used for 
cooling the tendons.  
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Table 1. LLLT irradiation intervals 
904 nm 810 nm 
Seconds (Joule) Seconds (Joule) 
MOP MOP 
1 (0.06) 1 (0.2) 
30 (1.8) 30 (6) 
60 (3.6) 60 (12) 
90 (5.4) 
120 (7.2) 
3.4.3 Study III 
All treatments were performed one hour after administering the tendon trauma. The 
LG, LCG, and CLG were treated with a single LLLT application using an infrared 
laser unit (DMC®, São Carlos, Brazil). The laser unit emitted a continuous optical 
output of 100 mW with a wavelength of 810 nm to a spot size area of 0.028 cm2, 
providing a power density of 3.57 W cm−2. Laser irradiation was performed with skin 
contact in the middle portion of the Achilles tendon. The laser delivered energy of 3 J 
in one single point, corresponding to an irradiation time of 30 s. The laser treatment 
parameters were chosen according to previous studies performed by our research 
group (Marcos et al., 2011; Marcos et al., 2012). 
The CTG, LCG, and CLG received cryotherapy to the injured Achilles tendons for 20 
minutes. Small rubber bags containing 10 g of crushed ice were fixed to the region of 
the Achilles tendon with rubber bands, and the hind limb was kept elevated. The ice 
came from a freezer that held a stable temperature of -20 °C.  
The HCG was not injured and not treated. The ING was injured but received no 
treatment.  
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3.5 Outcome measurement instruments 
3.5.1 Study I 
Methodological assessments of the included trials were scored using the 10-point 
PEDro scale. The intraclass correlation coefficient (ICC) for the total PEDro score is 
reported at 0.68 (CI=0.57–0.76) and interpreted to have “fair” to “good” reliability. 
Consensus scores are demonstrated to be in exact agreement with PEDro reviewers 
46% of the time and differs by 2 points or less 99% of the time (Maher et al., 2003). 
We interpreted scores differing by one point or less to be in line with PEDro.  
The WALT recommendations for treating tendinopathies with LLLT were used for 
examining the validity of the treatment procedure and the LLLT doses for each 
included trial. We used a calculation formula to compute the exact joules per point 
treated and total energy (J) per treatment session. LLLT treatment was ascribed as 
“inadequate” when LLLT doses ranged (± 50%) outside the stated therapeutic 
window regarding joules per point and/or total dose per treatment session. 
3.5.2 Study II 
Skin temperature was measured by a thermographic camera (Flir System, T640-25, 
USA) and ancillary software (FLIR Tools+). This software includes tools for 
quantifying the recorded temperature. The camera measures temperature with a 
precision of 50 millikelvin (mK) at 30°C and has an accuracy of ±2% 
(manufacturer’s specifications).  
The laser MOP was measured with an OPM system (Thorlabs Instruments, NJ, 
USA). The OPM system consists of a PM100 display unit with a sample rate of 6 
hertz (Hz), an accuracy of ±1%, and a S121B silicon sensor. The S121B sensor has 
an aperture diameter of ϴ=9.5mm with an optical power range of 500 nW to 500 mW 
and an accuracy of ± 5% (manufacturer’s specifications).  
The RTUS instrument was a Logiq-S8 (GE Healthcare, Minneapolis, USA). The unit 
has a 19” liquid-crystal display (LCD) screen and operates in B-mode with high-
 44 
definition speckle reduction imaging (SRI-HD), CrossXBeam resolution, and coded 
harmonic imaging. The linear matrix transducer (ML16-15-D) was tuned to a 
frequency of 12 megahertz (MHz). The RTUS instrument has a caliper (Somet INOX 
CHROM, Czech Republic) with measurement precision scaled in millimeters (mm).  
3.5.3 Study III 
The optical power output of the laser unit was measured before, halfway through, and 
after the experiment with a Thorlabs power meter (Thorlabs Instruments, NJ, USA).  
Skin temperature over the Achilles tendon area was measured before cooling, after 3 
mins, and after 10 mins of cryotherapy with a thermographic camera (Flir System, 
ThermaCAM S65HS, Boston, MA). 
Histology samples were photographed using a microphotographic camera (Dino-Lite 
digital microscope®, Dino-Eye AM-423X model, Brazil) connected to a personal 
computer. Standardized photos were taken of all groups at a magnification of 100× at 
the specimen level. 
A universal tensile test machine (zL2.5, Zwick, Roell, Germany) was used to perform 
mechanical testing of the tendons. 
Cytokine readings were performed in a Spectrum Max Plus 384 spectrophotometer 
(Molecular Devices Corporation, Sunnyvale, CA, USA) at a wavelength of 450 nm, 
with correction at 570 nm. Sample concentrations were calculated from standard 
curves obtained from the recombinant cytokines. 
3.6 Statistics 
3.6.1  Study I 
Two reviewers extracted data for analysis in the statistical software program Review 
Manager (RevMan) version 5.2. If insufficient data were reported in the original 
articles, authors were contacted to provide additional information. Testing for 
statistical heterogeneity was performed using the chi-square test, which determined 
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whether a random or fixed effects model was applied. Subgroup analyses were 
preplanned, as heterogeneity was expected in LLLT treatment parameters, 
composition of treatment interventions, and exercise designs. Sensitivity analysis was 
performed to reveal trials contributing to a statistical heterogeneity, and the meta-
analysis was considered to be valid if the inclusion of these trials did not influence or 
inflate the overall effect size. End-of-treatment data were pooled as follows. 
We extracted the means and standard deviation (SD) for comparisons using the 
outcome measures of pain, function, and active range of shoulder abduction. Pain 
intensity on a 100 mm visual analogue scale (VAS) and degrees of active abduction 
was defined as the pooled estimate of the difference in change between the means of 
the treatment and control groups, weighted by the inverse of the SD of change for 
each study (i.e., the weighted mean difference [WMD] of change between the 
groups). The variance was calculated from the trial data and presented as 95% 
confidence intervals in mm on VAS and degrees of abduction. Improved global 
health status was defined as any of the following categories: “improved,” “good,” 
“better,” “much improved,” “pain-free,” or “excellent.” The relative risk (RR) for 
change in health status was calculated by pooling the number of improved patients.  
Shoulder function was measured by several different disability scales. If pooling of 
the data was justified, the standardized mean difference (SMD) of change between 
groups with a 95% confidence interval were calculated. SMD is a unitless pooled 
estimate of the difference between the mean of the treatment and control group, 
weighted by the inverse of the pooled SD of change between the groups. 
3.6.2 Study II 
The mean (± the standard error of mean [SEM]) amount of laser energy (mW) 
penetrating the Achilles area was calculated pre- and post-cooling. The difference in 
energy penetration pre- and post-cooling is illustrated as the mean change in mW and 
percentage of MOP when measured directly into the OPM. The mean (±SEM) tendon 
and skin thickness pre- and post-cooling is displayed in cm. Energy loss per cm of 
tissue was calculated as MOP (mW, no obstacle) – MOP (mW, through tissue) / skin-
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to-skin tissue thickness in cm. Student’s pairwise t-tests were used for pre- and post-
cooling comparisons of energy penetration, tendon/skin thickness, and energy loss, 
with the statistical significance level set at p<0.05. Microsoft Excel (Microsoft Office 
Excel 2011) was used for statistical analysis and graphics. 
3.6.3 Study III 
The Kolmogorov–Smirnov test was applied to assess the normality of distribution of 
the dependent variables. The Kruskal–Wallis test, followed by pairwise comparisons 
using the Mann-Whitney U test, was used to test for differences between the ING and 
the four treatment groups (LG, CTG, LCG, and CLG). The HCG was compared to 
the ING to validate the trauma model. Biomechanical data and cytokine 
concentrations are expressed as medians and interquartile range. Differences were 
considered statistically significant at p<0.05. Tendon specimens were evaluated 
qualitatively for differences in collagen organization, tenocyte infiltration, and degree 
of eosin staining. To increase readability, the findings are presented quantitatively in 
a four-point histology score table, and the mean score for each group is reported. 
3.7 Ethics 
3.7.1 Study I 
There is no universally accepted standard for ethical assessments in systematic 
reviews (Vergnes et al., 2010). Consequently, no systematic ethical assessments 
beyond the standards stated by the original authors were performed in this study. 
3.7.2 Study II 
LLLT is considered harmless when applied to healthy tissue. Due to the consistent 
absence of adverse events and the lack of treatment intentions in this study, no special 
ethical approval was necessary. This was confirmed orally by the Regional 
Committees for Medical and Research Ethics (REK) prior to the start of the study.  
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3.7.3 Study III 
The protocol for Study III was approved by the University of Sao Paulo Animal 
Research and Care Committee (Appl. no 144/78-2). 
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4. Summary of results 
4.1 Study I  
All trials were of either moderate or high methodological quality (mean PEDro score 
of 7). While eleven studies (paper I, table 4) reported positive effects of LLLT, six 
studies reported no significant effects after LLLT treatment (paper I, table 5). 
Four of the studies with non-significant trial results were performed with inadequate 
LLLT dosages (paper I, table 5). Three of these studies used the Roland (IR 904, 
Pagani) laser device, which has been revealed as faulty, with power outputs less than 
1% of the stated output by the manufacturer (Bjordal, 2010). Although this is a 
potentially valid reason for excluding these papers from the review, these trials were 
subgrouped in the RevMan 5.2 analyses. 
Eleven out of 15 trials (73%) that reported pain relief on VAS favored laser over 
placebo, no treatment, or other modalities. Statistically significant (p<0.05) effect 
sizes were found in 9 of these trials (53%), of which 7 trials exceeded the minimal 
important change of 14 mm on the VAS (Tashjian et al., 2009). When trials with 
inadequate laser dosage were excluded, 10 out of 11 trials (91%) displayed pain 
reductions exceeding 10 mm on the VAS. The 7 trials that provided data on global 
improvement were all in favor of LLLT, 4 of these trials with statistically significant 
effect sizes.  
All included trials presented end-of-treatment data in a format that made it possible to 
use RevMan 5.2 for calculations of effect sizes in one or both of the primary outcome 
measures. Continuous data for pain relief on a 100 mm VAS was available from 13 
trials in a format that made statistical pooling possible. 
Following are answers to the four core questions posed at the beginning of Study I: 
I. Does LLLT work in shoulder tendinopathy patients? (Comparison with 
placebo LLLT and no therapy) 
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LLLT was found to be significantly better (p<0.0001) than placebo LLLT or no 
therapy at the end of treatment, with a WMD of 20.41mm (95% CI: 12.38–28.44) 
on the VAS (paper I, fig. 2). Data from 5 trials found LLLT to be significantly 
better (p=0.004) than placebo or no therapy, with an overall RR of improvement 
at 1.96 (95% CI: 1.25–3.08) (paper I, fig. 4). Two trials comparing LLLT to 
placebo showed significantly better (p<0.0001) shoulder function with a SMD of 
1.01 (95% CI: 0.53–1.50) at the end of treatment (paper I, fig. 5). 
II. Does LLLT work in combination with exercise? (Comparison with exercise 
and placebo LLLT) 
Data from two trials showed that LLLT and exercise were significantly better 
(p<0.0001) than exercise and placebo laser, with a WMD of 16.00 mm (95% CI: 
11.88–20.12) on the VAS (paper I, fig. 2). 
III. Does LLLT work in combination with several physiotherapy interventions? 
(Comparison with exercise and other modalities) 
When used as an adjunct to exercise and other therapies, LLLT was significantly 
(p=0.02) better than other therapies, with a pain reduction of 12.80 mm (95%CI: 
1.67–23.94) on the VAS (paper I, fig. 2). Two trials made statistical pooling on 
global improvement possible for LLLT as an adjunct to other interventions. The 
RR for improvement was significantly higher (p=0.006) at 1.51 (95%CI: 1.12–
2.03), in favor of LLLT (paper I, fig 4.). When LLLT was used as an adjunct to 
other interventions, improvement in shoulder function was not significantly 
different (p=0.27) from placebo laser, with an SMD of 0.33 (95% CI: -0.26–0.91) 
(paper I, fig. 5). We were able to pool data for shoulder function expressed as 
improvement in active shoulder abduction for two trials investigating the effect of 
LLLT as an adjunct to other interventions. Although the overall effect was 
negligibly in favor of laser therapy, the effect did not reach statistical significance 
(p=0.09), with a WMD of 8.08 degrees (95% CI: -1.27–17.43) (paper I, fig. 6).  
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IV. Does LLLT work better than other EPAs? (Comparison with other EPAs)  
Two trials compared laser therapy to ultrasound and both trials favored LLLT, 
with a significant effect size on the VAS. However, significant heterogeneity in 
treatment procedures and a lack of trial data did not justify statistical pooling 
(paper I, fig. 3). 
V. Trials subgrouped for not adhering to WALT treatment recommendations  
In trials performed with inadequate laser dosages, LLLT was not significantly better 
(p=0.38) than controls, with a WMD of 2.77mm on the VAS (95% CI: -3.46–8.99) 
(paper I, fig. 3). Shoulder function was not significantly different (p=0.26) from 
controls, with an SMD of -0.17 (95% CI: -0.48–0.13) (paper I, fig. 5). Data from 
three of the four trials with inadequate laser dosages showed no difference in active 
abduction with the application of LLLT, with a WMD of -0.08 degrees (95% 
confidence interval [CI] -0.81–0.65) (paper I, fig. 6). 
4.2 Study II  
The H1 hypothesis, “Laser optical energy penetration through the Achilles tendon 
area changes after 20 mins of cooling,” was confirmed, and the  H0 hypothesis, 
“There are no changes in energy penetration through the Achilles tendon area after 20 
mins of cooling,” was rejected. 
All study subjects (n=54) completed the experimental procedure according to 
protocol (paper II, fig. 1). The baseline room temperature was 21.9°C (SD ±0.7). 
Thermography recordings before cooling showed the Achilles mean skin temperature 
to be 28.2°C (SD ±1.8). Skin temperature dropped to a mean value of 4.8°C (SD 
±3.6) after 20 mins of cooling. 
MOP (no obstacle) 
The 904 nm laser was stable and not significantly different (p=0.22) during the 120 s 
pre-cooled and post-cooled irradiations at 54.5 mW (SD ± 2.41) and 55.2 mW (SD ± 
 51 
3.05) (p=0.22), respectively. The 810 nm laser was stable during the 60 s laser 
exposure period, at 202.7 mW (SD 3.75) before ice and 204.3 mW (SD 2.99) after 
ice. The MOP increased by 1.6 mW in the post-ice measurement, which was found to 
be a statistically significant increase (p<0.05).  
904 nm laser energy penetration before and after ice (per steps 4 and 7) 
Irradiation with the 904 nm laser showed a linear increase in tissue penetration with 
time (30 s–120 s), and during this laser exposure period, penetration increased by 
0.03 mW (19%) before cooling and 0.09 mW (45%) after cooling. The energy 
penetration after cooling was significantly increased (p<0.01) at all time intervals 
(30 s, 90 s, and 120 s) compared to the before-cooling measurements (paper II, 
fig. 3a, table 3).  
The percentage of energy penetrating the Achilles area during the exposure period 
was 0.34–0.39% of the MOP before cooling (i.e., a relative increase of 15%). The 
percentage of energy penetrating the same area was 0.43–0.52% of the MOP after 
cooling (i.e., a relative increase of 21% during the laser exposure period) (paper II, 
fig. 3b). Laser energy loss per cm of tissue was significantly (p<0.05) higher at all 
time intervals after cooling (paper II, fig. 4a).  
810 nm laser energy penetration before and after ice (per steps 4 and 7) 
Irradiation with the 810 nm laser showed a stable energy penetration during the 60 s 
exposure. Laser energy penetration at the interval 30 s–60 s increased 0.012 mW 
(2%) in non-cooled Achilles and 0.02 mW (3%) in cooled Achilles tendons. The 
amount of energy penetrating the tissue in the Achilles area after cooling was 
significantly increased (p<0.01) at all time intervals compared to the before-cooling 
measurements (paper II, fig. 5a, table 3).  
The percentage of energy penetrating the Achilles area was 0.24–0.25% of the MOP 
before cooling and 0.30–0.31% after cooling (paper II, fig. 5b), meaning there was a 
relative increase of 4% before and 3% after cooling during the laser exposure period. 
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Laser energy loss per cm of tissue was significantly (p<0.05) higher at all time 
intervals after cooling (paper II, fig. 4b). 
RTUS measurements before and after ice (per steps 2 and 8) 
The mean thicknesses of the Achilles tendons before cooling were 0.51 cm (SD 
±0.07) in the longitudinal (A-P size) images and 1.83 cm (SD ±0.40) in the 
transversal (M-L size) images. The total amount of tissue the laser should penetrate 
before cooling (i.e., the M-L size skin-to-skin distance) was 2.20 cm (SD ±0.30).  
After 20 mins of cryotherapy, the mean A-P thickness of the Achilles tendons were 
not significantly different (p=0.49) in longitudinal images compared to the before-
cooling measurements, at 0.51 cm (SD ±0.07). The mean transversal M-L Achilles 
tendon thickness after cooling was 1.77 cm (SD ±0.38) and was significantly reduced 
(p=0.03) compared to before-ice measurements. The M-L skin-to-skin distance after 
cooling was significantly reduced (p=0.05) compared to the before-cooling 
measurements, at 2.14 cm (SD ±0.34) (paper II, fig. 6). 
4.3 Study III 
The H1 hypothesis, “A single dose of cryotherapy followed by LLLT, or LLLT 
followed by cryotherapy, has an effect on inflammation and tendon biomechanics,” 
was confirmed. The H0 hypothesis, “A single dose of cryotherapy followed by LLLT, 
or LLLT followed by cryotherapy, has no effect on inflammation and tendon 
biomechanics,” was rejected. 
The biomechanical properties measured as force (N) and displacement (mm) at the 
rupture point were statistically different across the ING and the four treatment groups 
(X2 (4)=5.3, p=0.02 and X2 (4)=5.3, p=0.02, respectively). The expression of 
inflammatory cytokine IL-1β, TNF-α, and IL-6 were significantly different across the 
ING and the four different treatment groups (at X2 (4)=6, p=0.00; X2 (4)=18.5, 
p=0.00; and X2 (4)=5.9, p=0.00, respectively). No statistically significant differences 
across the groups for the expression of IL-10 was found at X2 (4)=2.5, p=0.64.  
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Combination of LLLT and cryotherapy (comparison against ING)  
The pairwise comparisons against the ING showed improved force (p=0.02) and 
displacement rates (p=0.04) for the CLG. The LCG showed significantly lower 
displacement (p=0.04), but there was no difference in force at the rupture point 
(p=0.15) compared with the ING (paper III, fig. 1, table 2). 
Both groups combining LLLT and cryotherapy showed significantly reduced levels 
of IL-1β (p=0.00, p=0.01) and TNF-α (p=000, p=0.02). The expression of IL-6 
increased significantly (p=0.00) in both groups, while IL-10 remained at levels 
(p=0.75, p=0.63) similar to those of the ING (paper III, fig. 2a–d, table 3).  
The histology analyses of the CLG showed a near-normal appearance, with no sign of 
tendon rupture. As seen in the healthy controls, the collagen bundles were lightly 
stained and largely uninterrupted. The distribution of tenocytes was situated regularly 
between the collagen bundles (paper III, fig. 3). As such, this group achieved a 
histology score of three, similar to that of healthy control tendons (paper III, table 4). 
The LCG showed consistent signs of moderate tendon rupture. There were larger 
regions of irregularly shaped collagen bundles and heterogeneous staining compared 
to the other treatment groups. Tenocytes were scattered irregularly around the lesion 
(paper III, fig. 3). This treatment group displayed morphological features that most 
closely resembled those of the ING, resulting in a total histology score of eight out of 
twelve in our analyses (paper III, table 4). 
Monotherapy groups (comparison against ING) 
Tendons treated with LLLT tolerated higher forces (p=0.04), but they were not 
significantly less displaced than the non-treated tendons (p=0.19). Tendons treated 
with cryotherapy were significantly less displaced (p=0.02), but they did not tolerate 
higher forces at the rupture point than the non-treated tendons (p=0.56). 
The LLLT group showed significantly decreased levels of IL-1β (p=0.00) and 
bordered the threshold for statistical significance (p=0.06) for IL-10 cytokine 
expression (paper III, fig. 2a/d). TNF-α expression was non-significantly (p=0.15) 
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reduced in the LLLT group (paper III, fig. 2b), whereas IL-6 expression remained 
equal (p=0.42) to that of the ING (paper III, fig. 2c). The cryotherapy group displayed 
cytokine expression in favor of an anti-inflammatory response, but no significant 
differences were found between the groups (paper III, fig. 2a–d).  
The histology analyses of the groups treated with LLLT or cryotherapy alone had a 
general appearance indicating slight tendon rupture. Small areas of irregularly shaped 
collagen bundles and disruption were evident, with somewhat larger regions of dark 
staining in the cryotherapy group compared with the LLLT group. The distribution of 
tenocytes was slightly disorganized, with small cluster formations around the lesion 
(paper III, fig. 3). LLLT and cryotherapy treatment resulted in total histology scores 






This thesis investigated the clinical, biological, and biophysical effects of LLLT 
alone and in combination with cryotherapy for the treatment of tendinopathy. To 
explore these issues, a systematic review, a basic research study on in-situ human 
tissue, and an RCT were the methodologies used. All these approaches are robust and 
well-established evidence-based research designs. Regarding the main purpose of the 
thesis, there is evidence from the systematic review that LLLT is effective if 
guidelines regarding dosage and application are followed. The systematic review 
identified cryotherapy as a possible confounder of LLLT, with the potential to induce 
inhibitory effects and negatively influence treatment outcomes for LLLT. 
Interestingly, our basic research study demonstrated that the penetration of laser light 
through healthy Achilles tendons increased significantly after 20 min of cryotherapy. 
Finally, the results of our RCT animal trial were polarized and showed both positive 
and negative biological effects using the combination of ice and LLLT, depending on 
the order of therapy administration. The rule of thumb from this study was as follows: 
ice followed by LLLT seems like a good idea, but LLLT followed by ice does not 
seem wise. These novel findings illuminate a new area in LLLT research and raise 
several questions that require further exploration and verification. The main points 
and issues raised in this thesis will be discussed in conjunction with current 
knowledge regarding LLLT and cryotherapy for the treatment of tendinopathy. The 
results in each of the studies have been discussed in the respective papers. In the 
following chapter, the general aspects, including the main findings in this thesis and 
methodological considerations across the studies, will be discussed.  
5.1  General discussion  
The history of physiotherapy is a tale of relatively young profession. The Chartered 
Society of Massage and Medical Gymnastics was established in the early 1920s with 
support from medical community (Chartered Society of Massage and Medical 
Gymnastics, 1929). Physiotherapy quickly became a profession that developed within 
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the framework of biomedicine, with a subordinate and assistive role to medical 
doctors. Physiotherapists have traditionally been dedicated the role of treatment 
executioners, leaving the defining powers of diagnostics to doctors. Since diagnostics 
guides therapy, much research into treatment methods for musculoskeletal diseases 
have been initiated and defined by others than physiotherapists. This can be easily 
illustrated by conducting a simple database search in PubMed. While a search 
combining the terms “low level laser therapy” or “cryotherapy” and 
“musculoskeletal” results in a little more than 200 papers, “non-steroidal anti-
inflammatory drugs” and “musculoskeletal” increase the amount of published papers 
fourfold. From this perspective, LLLT may still be regarded a novel treatment in 
musculoskeletal diseases compared to non-steroidal anti-inflammatory drugs 
(NSAIDs), even though both interventions arose as potential treatment options 
around 50 years ago (Adams and Cobb, 1967; Mester et al., 1967; Rainsford, 2007). 
Furthermore, early studies stating that low-level lasers could produce beneficial 
biological effects and act at a molecular level were met with skepticism and discredit 
by a majority of scientists. Consequently, the method of LLLT was established, and 
still remains, outside of mainstream medicine (Hamblin and Huang, 2014).  
The term evidence-based medicine (EBM) was introduced in the 1990s and marks a 
transition in patient decision-making processes. It is emphasized that clinical decision 
making should be based on the best level of evidence from clinical studies rather than 
subjective expert opinions and clinical expertise (Guyatt et al., 1992). Extending this 
idea, a hierarchical model for grading levels of evidence was suggested, placing a 
systematic review with meta-analysis at the highest level of evidence (Evans, 2003). 
Although the main purpose of systematic reviews is to summarize existing research 
on a topic and make judgements regarding evidence, an equally important task is to 
identify gaps in the existing literature and direct future research. The requirement to 
bring the best evidence into clinical decision making highlights the need for more 
research in physiotherapy-related interventions. The number of RCTs and systematic 
reviews published per year in the PEDro database increased from less than 500 in the 
early 1980s to more than 2,000 in the late 1990s, and along with this, there was also a 
 57 
substantial improvement in the methodological quality of the studies (Moseley et al., 
2002). The cumulative number of physiotherapy papers in the PEDro database has 
now exceeded 37,000 (PEDro, 2017). 
Another factor that has led to confusion in scientific and clinical laser therapy 
literature is the lack of consistency and consensus regarding terminology. The great 
heterogeneity in nomenclature has most likely contributed to a loss of momentum and 
increasing skepticism in the emerging field of LLLT. In addition to the term laser 
biostimulation, introduced by Mester et al. (1968b), other names such as cold laser, 
soft laser, low-power laser therapy, low-intensity laser therapy, and low-level laser 
(or light) therapy were used by the industry and researchers. Although LLLT is a 
well-established, searchable Medical Subject Headings (MeSH) term and extensively 
used by researchers, patients, and clinicians, it has been criticized for not accurately 
reflecting the variety of light sources used or the mechanisms of actions at play. In a 
nomenclature consensus meeting organized by WALT and the North American 
Association for Photobiomodulation Therapy (NAALT) in 2014, a majority of 
participants opted for photobiomodulation therapy as a more accurate and specific 
description of the therapeutic application of light (Anders et al., 2015). However, this 
term was not MeSH indexed at the time and was first included in the MeSH database 
as an entry term for “laser therapy, low level” in 2016.  
One major consequence of lacking adherence to a universal term is a neglect of the 
literature. Researchers may not be able to perform a comprehensive systematic search 
for literature if the many synonyms to LLLT and PBMT are not included. This 
limitation is not unique to the field of LLLT. A conglomeration of different terms has 
also been used to describe tendinopathy, which mirrors the uncertain pathophysiology 
driving the condition (Van Dijk et al., 2011). In literature, the move away from the 
term inflammatory tendinitis/tendinosis to degenerative non-inflammatory model of 
tendinopathy is evident (Rees et al., 2013). Consequently, studies containing both 
LLLT and tendinopathy are at risk of falling between the cracks and going unnoticed. 
This can be demonstrated by investigating the number of LLLT trials included in 
published systematic reviews of several shoulder tendinopathy interventions over the 
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past decade. We identified six systematic reviews that made conclusions regarding 
the effectiveness of LLLT for shoulder tendinopathy and were based on only a 
handful of studies, ranging from 1-4 RCTs (Green et al., 2003; Faber et al., 2006; 
Kromer et al., 2009; Valen and Foxworth, 2010; Gebremariam et al., 2013). In 
contrast, our systematic review and meta-analysis (Study I) includes a total of 17 
LLLT trials.  
The LLLT modality struggles to gain general acceptance in medical communities and 
remains controversial, much due to the uncertainties and confusion related to 
treatment parameters. A large number of parameters (e.g., wavelength, output power, 
irradiation mode, irradiation time, treatment timing, and repetition) can be chosen, 
showing the complexity of designing LLLT protocols (Nussbaum et al., 2003). 
Furthermore, the first law of photobiology states that for LLLT to have any effect on 
a biological system, a sufficient amount of energy from the irradiated light must be 
absorbed by photoacceptors in the targeted tissue. Consequently, if the amount of 
light energy delivered to the target tissue is too low, a response in the tissue will not 
occur. Conversely, if the amount of light energy is too high, inhibitory effects may 
occur. The existence of this biphasic dose-response phenomenon in LLLT has been 
frequently observed. Interestingly, this phenomenon contradicts our natural 
assumption that if a small dose of LLLT produces a significant therapeutic effect, a 
larger dose should produce an even greater effect (Hashmi et al., 2010; Huang et al., 
2011; Chung et al., 2012; Cotler et al., 2015). By acknowledging these challenges 
related to LLLT treatment dosages, a more refined interpretation of the many 
negative studies that have been published is appropriate. Rather than making firm 
conclusions that LLLT in general does not work, the key message should be that the 
laser parameters used in those particular studies were ineffective.  
To minimize dose issues related to the clinical application of LLLT, the WALT 
constructed guidelines for treating common conditions, such as tendinopathy and 
arthritis, based on the current best evidence from systematic reviews and meta-
analyses (WALT, 2006). These guidelines were made in an attempt to reveal optimal 
dose ranges (e.g., the biphasic dose-response window). To overcome the inadequacy 
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of reporting doses calculated from the laser spot size (energy density in J/cm2), 
WALT implemented the idea from Nussbaum et al. (2003) and suggested that the 
area size in cm2 should be replaced with energy (J) per point irradiated. The 
explanation for this decision can be illustrated by the following equation: two LLLT 
probes of different output power (500 mW, 1 mW) and different spot sizes 
(0.001 cm2, 1 cm2) were used for 8 s and 4 s, respectively. Dosage reported as energy 
density would be identical at 4 J/cm2 for both lasers, whereas the energy delivered to 
the tissue (in joules per point treated) is in fact completely different, at 4 J and 
0.004 J, respectively (Carroll, 2017). Consequently, one should not expect similar 
clinical results. Although the consensus agreement issued by WALT (2006) regarding 
reporting of LLLT parameters in clinical trials is comprehensive (including 
wavelength, power density, irradiation time, joules per point treated, number of 
points treated, and total dose in joules), the published guidelines only state 
recommendations for minimum total dose in joules, minimum joules per point 
treated, and number of points to treat (WALT, 2005). The guidelines contain no 
recommendations regarding irradiation time (i.e., a typical dose of 4 J can be 
delivered in 8 s with a 500 mW laser and 80 s with a 50 mW laser). Thus, more 
studies are needed to refine these guidelines and the optimal dose ranges for LLLT. 
Nevertheless, the validity of the guidelines has increased over the past ten years as 
systematic reviewers consistently report positive results across trials adhering to the 
recommendations, as opposed to trials using unsupported doses (Bjordal et al., 2008; 
Tumilty et al., 2010; Jang and Lee, 2012). The results from our systematic review 
(Study I) were not different. 
The identification of an optimal dose-response relationship is even more limited for 
the therapeutic use of cryotherapy in musculoskeletal conditions. To date, optimal 
recommendations regarding the mode, duration, and frequency of cryotherapy 
treatment for tendinopathy or other soft-tissue lesions do not exist. The basic 
rationale for applying cooling agents after soft-tissue injury is related to van ’t Hoff’s 
law, which states that for every 10°C reduction in tissue temperature, a two- or 
threefold decrease in the rate of chemical reactions will occur. The current best 
evidence for reducing metabolism and enzymatic activity in the early stages of injury 
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is limited to animal trials, which demonstrate optimal effects when the targeted tissue 
is cooled to temperatures between 5 and 15°C (Bleakley and Hopkins, 2010; Bleakley 
et al., 2012). Similar to treatment success in LLLT, the treatment success of 
cryotherapy depends on penetrating the skin barrier to reach deeper-situated 
pathology. Moreover, a sufficient amount of temperature reduction is necessary to 
modulate pathophysiological processes. At present, the transfer of basic scientific 
theory and results from animal trials to clinical cryotherapy trials on soft-tissue 
lesions is frequently unsuccessful (Bleakley et al., 2004). As no study has 
demonstrated temperatures below 20°C in human muscle tissue following 
cryotherapy, its potential to reduce metabolism in deeper-situated soft tissue has been 
questioned (Bleakley and Hopkins, 2010). Skin and adipose tissue have an insulating 
effect, and individual variations in skinfold thickness require different cooling 
durations to produce an identical temperature reduction (Otte et al., 2002). The target 
area for reducing temperature in human muscle tissue is often 2 cm beneath the 
subcutaneous tissue (Merrick et al., 2003), and the amount of adipose distribution 
varies within and between subjects.  
To our knowledge, no studies have investigated intra-tendinous temperature 
reductions following cryotherapy. Superficial tendons are usually covered by a thin 
layer of subcutaneous tissue and located at anatomical body parts that are not 
associated with great inter-subject variability in adipose distribution. The Achilles, 
lateral elbow extensors, and rotator cuff tendons have all been measured and located 
less than 1 cm from the skin surface in an RTUS study (Bjordal et al., 2003). Hence, 
a greater reduction in intra-tendinous temperature in superficially located tendons 
should be expected when compared with most muscles. 
Research studies may be biased and produce erroneous results due to the influence of 
both known and unknown variables. An adequately powered and well-designed RCT 
will, on average, limit the influence of many potential cofounders (Polit and Beck, 
2008). Concomitant therapy is a well-known confounder and, therefore, often 
imposed as an exclusion criterion in RCTs. This is especially true for pharmaceutical 
studies, where polypharmacy may induce harmful drug interactions (Bjerrum et al., 
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2003; Rothwell, 2005). In contrast, most physiotherapy interventions, including 
modalities used for treating tendinopathy, display limited potential to cause harm. 
Moreover, different interventions are often combined into a physiotherapy treatment 
regimen, targeting individual clinical findings and etiological characteristics of the 
specific tendon disorder at hand (Cook and Purdam, 2009; Kuhn, 2009; Seitz et al., 
2011; Magnan et al., 2014a). Although these multimodal treatment regimens are 
designed to optimize effect, the evidence for such an effect is unclear for many 
treatment combinations (Green et al., 2003; Rees et al., 2009; Hanratty et al., 2012).  
In our systematic review and meta-analysis (Study I), we identified cryotherapy as a 
possible negative confounding variable if administered parallel to LLLT in patients 
suffering from shoulder tendinopathy. This hypothesis emerged as a trial with high 
methodological and procedural quality but which displayed ineffective results across 
all reported outcome measures (Dogan et al., 2010). Indeed, we expected this trial to 
be in favor of LLLT, as the remaining 10 trials performed with adequate LLLT doses 
reported reductions in pain and/or accelerated improvement. Unique to this study was 
the use of cryotherapy as a co-intervention. Consequently, a reversed translational 
research strategy was used to explore the potential biophysical and biological effects 
of the treatment combination of LLLT and cryotherapy in tendinopathy treatment.  
5.1.1 Clinical effects of LLLT and cryotherapy 
Studies on animal and cell models show that LLLT can modulate pathophysiological 
processes in tendinopathy, predominantly by modulating inflammatory components 
and stimulating the tendon repair process (Bjordal et al., 2006a; Cotler et al., 2015). 
Similarly, cryotherapy may induce beneficial anti-inflammatory effects by reducing 
microcirculation and cell metabolism, in addition to its neuro-analgesic potential 
(Malanga et al., 2015). Consequently, both therapies display a mechanism of action in 
which pain relief seems to be the most important outcome measure. A more rapid 
course of improvement may also be expected if pain subsides and the tendon healing 
process is either stimulated by LLLT or the sequelae of a tendon injury is limited by 
cryotherapy. However, none of these therapies target other crucial etiological factors 
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in human tendinopathy, such as soft-tissue inflexibilities, impaired muscular 
activation pattern, loss of muscular strength or stability, or any environmental risk 
factor (Jarvinen et al., 2005; Seitz et al., 2011; Magnan et al., 2014a). Therefore, 
LLLT and cryotherapy should be considered as possible pain-modifying treatments 
and their usefulness in the clinical management of tendinopathy should be evaluated 
based on these premises. 
The current best evidence suggests that both LLLT and cryotherapy produce clinical 
effects in a dose-dependent manner. Evidence from animal studies show that a 
sufficient level of temperature reduction in the skin (<12°C) and soft tissue (5–15°C) 
is necessary to produce optimal clinical effects (i.e., pain relief and lower cell 
metabolism) (Bleakley et al., 2012; Bleakley and Hopkins, 2010). The critical 
threshold for skin cooling deemed necessary to produce cryo-analgesia can be easily 
achieved in humans using ice-based cryotherapy modalities (Merrick et al., 2003), as 
demonstrated in Study II, in which domestic ice-cube application to the Achilles area 
produced a mean skin temperature value of 4.8°C in healthy adults. However, skin 
temperature is a weak predictor of deeper-situated tissue temperature (Jutte et al., 
2001), and the ability of cryotherapy to lower temperature to the threshold for 
metabolic reduction seen in animal studies (5–15°C) may not be possible in most 
human soft-tissue disorders (Bleakley et al., 2012). Furthermore, these emerging 
recommendations for cryotherapy must be validated in rigorous clinical trials, across 
different soft-tissue injuries and pathological stages, before any firm conclusions 
regarding dose-response relationship can be established. As yet, no clinical trials have 
attempted to investigate the effects of cryotherapy alone or as an adjunct to LLLT in 
human tendinopathy. 
The effect of cryotherapy as a supplement to therapeutic exercises have been 
investigated in two controlled clinical pilot trials, which included patients suffering 
from lateral elbow and rotator cuff tendinopathy. Parle et al. (2016) found significant 
improvements in pain and shoulder function in the presence of reduced bursal 
thickness following one week of cryotherapy or isometric exercises alone. There were 
no significant differences between the groups and there was no evidence for any 
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“add-on” effect when these two therapies were combined in a third treatment arm. 
The authors submitted no information regarding cryotherapy treatment parameters. 
Manias and Stasinopoulos (2006) investigated the potential “add-on” effect of 10 min 
of ice-bag application (five times a week for four weeks) post eccentric exercises in 
lateral elbow tendinopathy (LET), compared to exercise only. The authors concluded 
that the magnitude of pain relief did not differ between the two groups at the end of 
treatment. However, the validity of these preliminary results is very limited, as they 
arise from two small pilot trials of poor methodological quality. Hence, it is not 
reasonable to make any conclusions regarding the clinical benefit of using 
cryotherapy as a supplement to exercise in human tendinopathy. 
There is evidence from previous systematic reviews that LLLT is effective for 
treating Achilles tendinopathy and LET if the currently recommended dosage 
guidelines issued by WALT are followed (Bjordal et al., 2008; Tumilty et al., 2010). 
Results from Study I supported the existing evidence and demonstrated that LLLT 
can produce beneficial clinical effects alone, as an adjunct to exercise or a 
multimodal physiotherapy regimen in shoulder tendinopathy patients. Our results 
demonstrated significant pain relief and accelerated recovery rates if LLLT was 
included across these intervention strategies. 
Interestingly, the Dogan et al. (2010) trial, which combined LLLT, exercise, and 
cryotherapy, displayed a WMD for pain relief and an SMD for shoulder function at 
0.4 cm and -0.33 over placebo, respectively. These effect sizes are almost identical to 
the trials subgrouped for using non-valid laser treatment doses. Although this high-
quality study (10/10 PEDro score) adhered to the treatment recommendations issued 
by WALT, no measures of laser output testing were reported. Consequently, laser 
device failure or errors in actual irradiation dose cannot be excluded as a possible 
confounding factor. 
In Study II, we discovered that 20 min of cryotherapy significantly decreased skin-to-
skin and Achilles tendon M-L thickness. Furthermore, we found that penetration of 
laser light increased significantly through healthy Achilles tendons subjected to the 
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cryotherapy treatment protocol. Dogan et al. (2010) treated all patients with 10 min 
cold pack application. It is possible that the duration of cryotherapy treatment and 
choice of modality (cold packs) used in this study predominantly produced 
temperature reductions in the skin. Merrick et al. (2003) reported an overall 
temperature reduction of only 5°C 1 cm sub-adipose tissue and a superficial skin 
temperature of 12°C after 10 min of cold pack application to the thigh of healthy 
adults. Levy et al. (1997) investigated subacromial space temperature following 90 
minutes of cryotherapy (Cryo/Cuff) in post-operative shoulder arthroscopy patients 
and found that the subacromial temperature was similar to controls. It can be argued 
that the cryotherapy treatment protocol used by Dogan et al. (2010) targeted the skin 
and did not penetrate the rotator cuff tendons situated in the subacromial space. With 
regard to the results in Study II, this would have allowed LLLT to penetrate the skin 
with less energy attenuation and perhaps “over-dose” the tendon tissue. Indeed, 
Dogan et al. (2010) treated patients with an 850 nm infrared laser (100 mW MOP) 
and irradiated each point with 6 J, which is an energy dose in the absolute upper 
margin according to WALT recommendations. However, the authors did not report 
the order of therapy administration, and cryotherapy may have been applied after 
LLLT treatment. 
In Study III, we found that LLLT followed by cryotherapy produced counter-
productive biomechanical and histological effects in acute Achilles tendinopathy of 
rats. The immediate application of a cooling agent on injured LLLT stimulated 
tendons and seemed to interfere with some cellular responses in a non-beneficial 
fashion. Conversely, superior effects were observed in the group treated with 
cryotherapy followed by LLLT. 
To the best of our knowledge, no other clinical trials have examined the effect of 
LLLT in combination with cryotherapy in tendinopathy treatment. It should be 
mentioned that the trial by Yeldan et al. (2009), which is included in Study I, also 
combined LLLT, cryotherapy, and exercise. However, the findings of this trial were 
deemed invalid because the participants were treated with a discredited laser device, 
which had a MOP output of less than 1% of the displayed dose (Bjordal, 2010).  
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5.1.2 Biophysical and biological effects of LLLT and cryotherapy  
Physiotherapy interventions such as LLLT and cryotherapy are applied to the human 
skin for the purpose of triggering biological actions in underlying tissue. The 
penetrative ability of both therapies depends primarily on mode of delivery (i.e., 
wavelength for lasers and the thermodynamic properties of the cooling agent for 
cryotherapy) (Merrick et al., 2003; Bashkatov et al., 2011). The amount of dermal 
and adipose tissue between the skin surface and the underlying target is obviously of 
great importance. Although the depth to tissue target should affect both cryotherapy 
and LLLT treatment parameters, it has not been a prioritized area of research and is 
seldom reflected in clinical treatment protocols. The WALT consensus agreement on 
the design and clinical conduct of LLLT studies has not been revised since its release 
in 2006 (WALT, 2006). An updated version should perhaps encourage researchers to 
include ultrasonography measurements of dermal tissue thickness in LLLT 
tendinopathy trials. This would allow for future assessments of correlation between 
inter-subject variability in “depth to target tissue” and magnitude of effect. Indeed, 
such evidence is important to refine, optimize, and individualize the treatment 
parameters of both LLLT and cryotherapy. 
It has also been demonstrated that the biophysical penetration of laser light is 
influenced by skin color. LLLT doses within WALT recommendations increased skin 
temperature beyond the threshold for painful thermal stimuli in people with dark skin, 
whereas the skin temperature in those with light/medium skin tones remained 
negligible (Joensen et al., 2011). The melanosomes of dark skin are heavily 
pigmented, which increases the ability to absorb ultraviolet light (Yamaguchi et al., 
2007). Hence, dark skin most likely acts as a more efficient photon barrier than 
lighter skin tones can during LLLT irradiation. Skin color in relation to biophysical 
penetration of cryotherapy and thermodynamics has not been investigated. However, 
skin structure and function are known to vary across different ethnic skin types 
(Rawlings, 2006), and their response to heat or cold application may also differ 
(Taylor, 2006; Lee et al., 2010). 
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How the biophysical penetration of LLLT and cryotherapy is influenced by variables 
such as gender, age, disease, activity level, and various drugs are also unknown. 
Interestingly, the co-contaminant use of the cortisol antagonist mifepristone 
completely blocked the anti-inflammatory effect of LLLT in the carrageenan-induced 
pleurisy of mice (Lopes-Martins et al., 2006). The authors explained this negative 
event as resulting from a steroid-induced downregulation of cortisol receptors, 
suggesting that the effect of LLLT may depend on the cortisol/adrenal gland 
pathway. Notably, when the adrenal glands responsible for endogenous cortisol 
secretion were excised in rats, an inhibition or even a blockade of LLLT effects 
occurred (Albertini et al., 2004). It is also well known that corticosteroid treatment is 
able to produce a downregulation of its receptors (Silva et al., 1994; Felszeghy et al., 
1996; Zovato et al., 1996; Sanden et al., 2000), which in clinical situations may be 
responsible for the poor effects of LLLT in patients submitted to corticosteroid 
therapy. However, skin atrophy and hypopigmentation are well-known side effects of 
both local and systemic steroid use (Schäcke et al., 2002; Liang and McElroy, 2013; 
Coondoo et al., 2014). Consequently, the biophysical penetration of LLLT may 
increase through skin and possibly “over-dose” the underlying target tissue if 
administered parallel to steroid treatment. With regard to Study II, careful 
consideration should be given before generalizing the results to a heterogeneous 
general population of varying ages, activity levels, skin colors, pathologies, and 
pharmaceutical histories. 
We have shown that skin and tendon thickness is significantly reduced after 20 min 
of ice pack application to the Achilles area of healthy adults with light skin color. The 
total amount of tissue reduction (skin-to-skin distance) following cryotherapy was 
small (0.6 mm/2.7%) but may have contributed to the increased LLLT energy 
penetration observed in Study II. Optical energy penetration increased significantly 
for both lasers and at all measured time points after cryotherapy application. Laser 
energy may penetrate more easily in cooled tissue due to reduced skin and tendinous 
microcirculation and the amount of laser energy–absorbing hemoglobin (Knobloch et 
al., 2007; Yanagisawa et al., 2007). It is also possible that the reduced attenuation of 
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laser energy reflects the slowing of cell metabolism in cooled tissue. Conversely, heat 
therapy is frequently used by physiotherapists to increase blood flow, cell 
metabolism, and the elasticity of collagenous tissue (Malanga et al., 2015). Future 
studies should investigate whether heat induces the opposite effect on the optical 
properties of skin and tendon tissue (i.e., increases the attenuation of LLLT). 
The combination of cryotherapy and LLLT also produced different biological effects 
in acute Achilles tendinopathy of rats when compared to the effects of LLLT or 
cryotherapy alone (Study III). This finding suggests that some cellular or tissular 
interaction occurred. LLLT induces photochemical actions on mammalian cells by 
increasing the activity of the enzyme CCO in mitochondria (Hamblin, 2016), which 
in turn modulates cellular responses responsible for limiting inflammation and 
stimulating tendon repair. Merrick et al. (1999) investigated whether five hours of 
continuous local cryotherapy reduced secondary injury after crush injury to skeletal 
muscle in rats. In this study, triphenyl tetrazolium chloride (TTC) reduction rates in 
assayed muscle tissue served as a measurement of CCO activity and was found to 
significantly increase in injured rats treated with cryotherapy, thus limiting the 
magnitude of the secondary injury. It has also been demonstrated that acclimation to 
low temperatures provokes a compensatory increase of CCO activity in fish and in 
the adipose tissue of hamsters (Klingenspor et al., 1996; Hardewig et al., 1999). 
Our study on Achilles tendinopathy of rats demonstrated that cryotherapy in 
combination with LLLT was the only intervention that significantly reduced the 
expression of all pro-inflammatory cytokines, thus displaying evidence for an anti-
inflammatory add-on effect, despite which therapy was administered first or last. This 
may reflect a reinforced upregulation of CCO activity when these therapies are 
combined. However, the effect on tendon biomechanics and histology was only 
positively influenced if LLLT was applied after cryotherapy. In fact, tendons treated 
with LLLT before cryotherapy negatively influenced these outcomes, which suggests 
that the order of therapy administration is essential to achieving a beneficial effect.  
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The photons emitted from LLLT irradiation is suggested to increase CCO activity in 
damaged cells by liberating it from the inhibitory actions of nitric oxide (Hamblin, 
2016), but the exact mechanisms of action for cryotherapy remain unknown. 
However, a decreased formation of NO has been demonstrated in heart muscles of 
hypothermic rats subjected to myocardial inflammation (Scumpia et al., 2004). NO is 
a potent signaling molecule that can activate both beneficial and harmful immune 
responses (Bogdan, 2001). The NO released by LLLT may induce different intra- and 
inter-cellular signaling pathways in cooled tissues compared to those of tissues at a 
normal temperature, producing a beneficial biomechanical and histological outcome 
in the CLG and a negative response in the LCG, as observed in Study III.  
Another aspect to consider regarding Study III is timing of LLLT intervention. It is 
well established that LLLT limits inflammation and promotes tendon healing in a 
laboratory setting (Oliveira et al., 2009; Marcos et al., 2011; Marcos et al., 2012; 
Laraia et al., 2012; Tsai et al., 2012; Casalechi et al., 2013; Torres-Silva et al., 2015). 
Indeed, LLLT alone significantly reduced pro-inflammatory cytokine IL1 expression 
in the presence of increased levels of IL-10 in Study III. However, we were surprised 
that the anti-inflammatory response was not more profound and included a significant 
reduction of the pro-inflammatory cytokine TNF-a. The optimal time frame for 
initiating LLLT treatment after injury is still an open question in the literature. In 
Study III, rat Achilles tendons were irradiated with 3 J one hour after crush injury, 
which is a recommended irradiation dose for human inflammatory conditions 
according to WALT treatment guidelines. It is possible that an irradiation dose of 3 J 
was a case of “too much, too soon” to achieve an optimal anti-inflammatory effect in 
small rodents. Indeed, increased Achilles tendon edema has been demonstrated in rats 
treated with a similar dose (3 J) 30 min after blunt injury (Joensen et al., 2012). 
However, the optimal LLLT dose may also differ depending on which trauma model 
is used to inflict tendon injury in animals. It is likely that the course of inflammation 
and the cytokine expression profile varies between different trauma methods. COX-2 
gene expression was found to peak 2 hours after injury in collagenase-induced 
Achilles tendinopathy of rats, and a single LLLT dose of 3 J was more effective than 
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1 J in reducing inflammation one hour after injection (Marcos et al., 2011). Another 
study with LLLT treatment one hour after collagenase-induced tendinopathy in rats 
demonstrated significant reductions in COX-2 and pro-inflammatory markers IL-6 
and TNF-a after 3 J but not after 1 J (Torres-Silva et al., 2015). Conversely, de 
Almeida et al. (2014) treated rats with LLLT one hour after blunt muscle injury and 
found significantly reduced TNF-a levels after 1 J but not after 3 J. Both de Almeida 
et al. (2014) and Joensen et al. (2012) used a similar injury model as did Study III, 
and in retrospect, these findings suggest that the early initiation of LLLT treatment 
after blunt injury to tendons should be performed with a lower dose than 3 J. 
5.2 Methodological discussion  
The research question for this thesis was to investigate the clinical, biophysical, and 
biological effects of LLLT alone and in combination with cryotherapy for the 
treatment of tendinopathy. Hence, the target tissue in all the three included studies are 
tendons. This section addresses the methodological aspects of the thesis with an 
emphasis on research design, subjects, and internal and external validity. Specific 
methodological limitations of the individual studies are presented separately in 
subsections.  
5.2.1 Study design and study population  
Systematic review and meta-analysis (Study I) are powerful tools for collecting and 
summarizing existing knowledge in a research field and for combining the results of 
individual studies in one paper (Laake et al., 2007). The aim of Study I was to 
investigate the clinical effectiveness of LLLT for shoulder tendinopathy by 
synthesizing evidence from already-published RCTs. Heterogeneity across trials 
related to procedural aspects of LLLT treatment and different co-interventions to 
LLLT was expected and formed the basis of our a priori subgrouping (Chapter 3). 
The review question was formulated using the population, intervention, comparison, 
outcome (PICO) model (Table 2, below), and these parameters constituted the basis 
of our systematic literature search. The subjects in Study I originate from RCTs of 
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patients diagnosed with shoulder tendinopathy or SAIS. The diagnostic accuracy of 
the clinical tests used to confirm SAIS and shoulder tendinopathy are known to be 
limited (Hegedus et al., 2008). However, rotator cuff disorders are by far the most 
common associated source of shoulder pain, accounting for more than two thirds of 
all cases (Murphy and Carr, 2010). These limitations in clinical diagnostics may 
cause some subject heterogeneity across trials, which could arguably impose a threat 
to the internal validity of Study I. Perhaps more importantly, the subjects in Study I 
most likely mimic the diversity of shoulder tendinopathy patients treated by 
clinicians, which is a crucial element for the generalization of the findings to clinical 
practice.  
In Study II, the biophysical ability of LLLT energy (from two different Class 3B 
lasers) to penetrate healthy human Achilles tendons was measured before and after 
cryotherapy, and at several time points during exposure (Table 2). The amount of 
optical LLLT energy penetration before cryotherapy was compared—using a similar 
part of the body, the Achilles—to that after cryotherapy (i.e., the subjects were their 
own control). This basic in-situ research study follows a repeated measurements 
design, which is sensitive in detecting differences within the same subject. The 
healthy subjects in Study II were recruited by nonprobability convenience sampling. 
This non-random method of recruiting participants limits the ability to generalize 
findings (Polit and Beck, 2008), but a conservative interpretation of the results can 
still yield important and clinically relevant knowledge.  
In Study III, a blinded multiple-armed RCT design with post intervention test only 
was used to investigate the biological effects of LLLT and cryotherapy as 
monotherapies, as well as in combination with each other (Table 2). The study 
population comprised in vivo rat Achilles tendons. Animals included in this study 
were (outbred) male Wistar rats of the same age and weight, produced at the Biotery 
of Sao Paulo University, comprising a homogenous study sample. The rats were 
randomly divided into six experimental groups. The probability sampling using 
random assignment increases internal validity by reducing bias related to pre-existing 
differences between the groups before the experiment begins (Polit and Beck, 2008).  
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Table 2. PICO key components of individual studies 
Study no. Population Intervention Comparison Outcome 




LLLT (Class 3B) 
administered to one 
group in the 
controlled trial  
Placebo LLLT or 






placebo LLLT or 






II Achilles tendons of 
healthy young 
adults  
 LLLT (Class 3B)  
Cryotherapy 












III Achilles tendons of 















5.2.2 Internal validity  
All research studies should be evaluated based on their internal validity, and if it is 
found to be adequate, they should then be evaluated based on their results and 
external validity (Biondi-Zoccai et al., 2011). The level of internal validity reflects 
how confident one may be that the dependent variable (outcome) was caused by the 
independent variable (intervention) rather than some other variable (Polit and Beck, 
2008). All three studies in this thesis were performed with detailed predefined 
protocols and standardized procedures to minimize biases, and they were controlled 
for the influence of possible extraneous variables. 
Study I 
The systematic review and meta-analyses (Study I) included as part of this thesis 
followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
(PRISMA) statement and was conducted with an a priori methodological approach 
(Moher et al., 2009). With PRISMA, several measures are taken to ensure that the 
review process is clearly defined, thereby establishing a framework for 
reproducibility of the results by other researchers and limiting potential sources of 
bias. However, the protocol for Study I was not registered in the PROSPERO 
database, which reduces the transparency of this a priori process.  
A comprehensive literature search strategy, adequate coverage of relevant databases, 
article reference screening, and personal contact with experts in the field were 
conducted to identify relevant trials for inclusion. No language restrictions or 
exclusions of “old” studies were imposed, to limit selection bias. Grey literature (e.g., 
unpublished trials) was not included in Study I, and their exclusion can lead to 
exaggerated estimates of intervention effectiveness (McAuley et al., 2000). However, 
as negative publication bias has been reported in LLLT literature, a devalued estimate 
of effect sizes seems like an equally likely outcome (Bjordal et al., 2008). 
The internal validity of LLLT trials depends on both methodological and procedural 
quality. There is no universal agreement or gold standard regarding which checklist 
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to use for methodological assessments of RCTs, and different quality scores for the 
same study may be reported across different systematic reviews (Olivo et al., 2008). 
The PEDro scale used for assessing trials in Study I was developed for use in 
physiotherapy and is a reliable and valid instrument (Maher et al., 2003; Macedo et 
al., 2010; Sherrington et al., 2010). According to the study by Maher, consensus 
scores were in exact agreement 46% of the time and differed by two points or less 
99% of the time. The ICC for the total PEDro score has been reported to range from 
0.68 to 0.91 (i.e., acceptably good reliability) (Maher et al., 2003; Foley et al., 2006). 
However, some disagreement between independent reviewers should be expected. 
For Study I, any disagreement in the rating of individual items between the two 
independent reviewers was solved by consensus, and scores differing by one point or 
less were interpreted to be in line with PEDro reviewers. For only one trial were 
reviewers in significant disagreement with the PEDro reviewers, and the results 
outlining this discrepancy were made available in the appendix of the published 
paper. 
The assessment of possible confounders related to LLLT treatment parameters and 
procedures were handled according to the standards issued by the WALT 
musculoskeletal advisory board, and trials using non-optimal treatment doses were 
subgrouped (WALT, 2006). The justification and validity of applying these standards 
in systematic reviews and meta-analysis of LLLT trials have been discussed in the 
general section. 
Two reviewers extracted data from the primary studies for the purpose of statistical 
pooling. There is an ongoing debate regarding how to handle cases of significant 
statistical heterogeneity (I2 > 0%, p< 0.05), and whether reviewers should avoid 
performing meta-analysis in such cases (Biondi-Zoccai et al., 2011). Higgins et al. 
(2003) investigated 509 meta-analyses of dichotomous outcomes in the Cochrane 
Database of Systematic Reviews and found that a quarter displayed I2 values over 
50%. Moreover, adjectives were suggested to interpret the degree of heterogeneity as 
follows: low (25%), moderate (50%), and high (75%). Although no attempt was 
made to categorize the meta-analysis of our study, sensitivity analyses were 
 74 
performed to reveal trials contributing to statistical heterogeneity. If the inclusion of 
these trials did not increase the overall effect size and the random or fixed effect 
model produced similar effect estimates, the meta-analysis was considered valid.  
Study II 
The within-subject repeated measurement design was used to investigate the 
penetration of laser energy through healthy Achilles tendons under two different 
conditions: before and after cryotherapy. An a priori power analysis was not possible 
to perform, as no similar studies containing expected means and variance data had 
been published (D’Amico et al., 2001). However, our study sample consisted of 54 
healthy tendons, which decreased the probability of beta errors (i.e., the probability of 
not finding a difference when one truly exists). The repeated measurement design 
also reduces error variance associated with individual differences between subjects, 
as they are their own control. In RCTs, important differences may exist between the 
two groups, which effects the dependent variable (Bordens and Abbott, 2002). While 
threats to internal validity such as history, maturation, and “carryover effects” are 
well-known disadvantages of this design, they do not apply in this study as the time 
interval between measurements (before and after cryotherapy) is limited to 20 min 
(Kirk, 1982, Polit and Beck, 2008). The internal validity of this study is largely 
dependent on the reduction of extraneous variables in the experimental set up, as well 
as the use of reliable measurement instruments and procedures.  
Two Class 3B lasers (an 810 nm 200 mW CW-mode laser and a 904 nm 60 mW 
SPW-mode laser) were used for irradiation of the Achilles tendons. Both lasers 
displayed a stable MOP during irradiation with no obstacle measured before and after 
cryotherapy. However, a small but significant increase in the 810 nm laser MOP (1.6 
mW) was observed in the after-cryotherapy measurement. Although we handled this 
inconsistency in our analysis by reporting the percentage of MOP penetrating the 
Achilles before and after cryotherapy, randomization of the intervention order could 
have eliminated this weakness. To obtain reliable measurements of non-cooled tissue, 
the tissue temperature must return to baseline levels after cryotherapy. The restoration 
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of skin temperature to baseline levels following cold-air exposure was found to 
exceed two hours (Kim et al., 2002), and the relationship between skin surface 
temperature and underlying tissue temperature is poorly understood (Hardaker et al., 
2007). The experiment could have been performed on consecutive days, but this 
approach was not taken because of the increased risk of influence from extraneous 
variables within subjects and “loss to follow-up.” 
Skin temperature was measured by thermographic imaging (Flir System, T640-25). 
Modern thermographic cameras have a small error rate of only ±2% and can produce 
high-definition infrared images with an accuracy of 0.1ºC in skin temperature 
measurements (Jiang et al., 2005; Villaseñor-Mora et al., 2009). Abnormal body 
temperature is a natural indicator of illness, and thermographic imaging has been 
successfully used in the diagnoses of several medical conditions, including breast 
cancer, neuropathy, vascular disorders, and chronic joint and tendon disorders (Ring 
and Ammer, 2012). This imaging technique is based on the phenomenon that 
different materials emit infrared thermal radiation, which can be used for calculating 
the temperature of the emitting object and visualizing it in real-time images. The 
emissivity of objects range from 0 (no emission) to 1 (complete emission), and the 
emissivity of human skin has been found to be almost constant, at 0.96 to 0.98 in both 
white and dark skin colors (Lahiri et al., 2012; Ring and Ammer, 2012). The 
reliability of thermographic temperature measurements can be affected by 
environmental changes in temperature, airflow, and moisture (Ring et al., 2004). The 
mean room temperature in our laboratory was 21.9ºC and varied less than 1ºC 
throughout the experiment; air filtered through a balanced ventilation system and the 
windows were double-glazed. 
Another factor to consider is the distance from the camera to the target measurement 
area (the Achilles), as this parameter can influence the pixel resolution. In Study II, a 
standardized distance of 50 cm was used for all measurements, as recommended by 
Ring and Ammer (2000). The skin surface temperature can also be affected by topical 
substances such as ultrasound gel or water from the ice packs (Bernard et al., 2013). 
Although measures were taken to ensure that the skin surface was dry before images 
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were captured, the skin surface temperature at a baseline would perhaps have been 
more reliable if the images were captured before the ultrasound examination. In a 
review by Costello et al. (2012), the use of thermal imaging to assess skin 
temperature following cryotherapy was investigated, and the authors concluded that 
thermal imaging appeared to be a safe, accurate, and reliable method of collecting 
such data.  
The Achilles area (skin and tendon) was scanned in the longitudinal and transverse 
plane using an ultrasonography instrument (Logiq-S8, GE Healthcare, Minneapolis, 
USA). A built-in caliper was used to measure the amount of tissue. Images were 
obtained in a standardized manner at 2.5 cm from the tip of the OS calcaneus bone. 
The inter- and intra-observer reliability of Achilles tendon thickness measurement has 
been reported as high (Bjordal et al., 2003; Ying et al., 2003; Brushøj et al., 2006). 
The stability of the laser MOP and the relative loss of energy after penetrating 
through skin-tendon-skin was measured with an OPM (ThorLabs model PM100 with 
a S121B optical sensor). This instrument measures power output at five specific 
wavelengths, including 810 nm and 904 nm, which corresponds to those of the two 
LLLT devices used in Study II. OPM systems are widely used to measure and control 
laser parameters and are associated with a high degree of stability and low occurrence 
of measurement errors (Chen et al., 2016). 
Study III 
Evidence hierarchies often rank well-designed individual RCT studies on the second 
rung in evaluating healthcare interventions, below the strongest evidence, which 
comes from the systematic review of multiple RCT studies (Polit and Beck, 2008). 
The aim of Study III was to investigate the biological effects of LLLT and 
cryotherapy as mono- and combined therapies on the tendon mechanical properties, 
inflammation and histology. Even though the rats form a homogenous group, the 
induction of injury to the tendon may still produce some variation between the study 
subjects. Hence, manually assigning animals to specific groups may cause selection 
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bias and ultimately influence the results (Van der Worp et al., 2010). The failure to 
randomize animals and employ blinded outcome assessors are associated with 
exaggerated effect sizes across several different disease areas (Hirst et al., 2014). In 
this study, the animals were randomly divided into six different cages by one person, 
and group allocation was decided by another blinded researcher. However, 
randomization does not ensure an unbiased comparison of the treatment groups. In 
clinical trials, the most robust method of limiting systematic bias is to employ a 
double-blind, placebo-controlled procedure, meaning neither the patient, researcher, 
nor caregiver know the details of the treatment given (Laake et al., 2007). As animals 
are not likely to experience any placebo effect, double-blinding procedures are not 
necessary (Van der Worp et al., 2010). Given the nature of the treatment intervention 
in our study, blinding the caregiver was not possible. However, we ensured that the 
outcome assessors were unaware of the group allocation. Tendon biomechanical tests 
can only be performed once, as the tendon ultimately ruptures. Two independent 
blinded assessors performed the histology and cytokine analysis to ensure the 
consistency of the analyses. 
ELISA is the most widely used and best-validated method for measuring individual 
inflammatory cytokine expression. The high sensitivity ELISA from R&D Systems, 
as used in Study III, has been reported as having a sensitivity of less than 1 picogram 
per milliliter (pg/ml) for IL-1, IL-6, and IL-10 measurements (Leng et al., 2008).  
The evaluation of biomechanical properties using a tensiometer has been widely used 
in animal research (Ferry et al., 2007; Joensen et al., 2012; Marcos et al., 2012; 
Marcos et al., 2014). In Study III, the tendons were attached to a universal tensile test 
machine (zL2.5, Zwick, Roell, Germany), and several bouts of loading and unloading 
sequences with increasing strength were performed until the tendon ruptured. A 
major prerequisite for obtaining reliable measurements is to avoid slipping of the 
tendon grip as tension increases. The musculotendinous junction was firmly fixed at 
the bottom, whereas the osteotendinous junction was fixed at the top of the 
tensiometer grip. This procedure reliably measured the force and displacement 
needed to rupture the healthy control tendons of the rats. 
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An a priori power analysis was not possible to perform, as no studies containing 
expected means and variance data for the treatment combination of LLLT and 
cryotherapy had been published. We requested a total of 36 rats (i.e., six rats per 
group), based on experience from previous animal studies conducted by our research 
group (Marcos et al., 2011; Torres-Silva et al., 2015). Also, six animals should be 
sufficient according to the following power calculation and our estimate of cytokine 
expression due to LLLT treatment. A previous study by our group investigated the 
effect of LLLT on expression of inflammatory mediators in rat Achilles tendinopathy 
(Torres-Silva et al., 2015). Using the means for IL-10 (15 SD±2 for the injured 
controls, 19 SD±0.5 for the LLLT group) and TNF-a (35 SD±1 for the injured 
controls, 18 SD±3 for the LLLT group), we calculated an effect size of 2.7 and 7.6, 
respectively. Hence, conducting a power analysis (using G*Power software) for the 
difference between independent means (two-tailed t-test) with these effect sizes 
revealed a sample size of two to four rats per experimental group.  
5.2.3 External validity  
External validity refers to the generalization of results from tightly controlled 
research settings to real-world clinical practice settings (Polit and Beck, 2008). From 
this perspective, some shortcomings across the included studies of this thesis require 
that the results should be interpreted with caution. 
In Study I, the included subjects most likely represent a subsample of the target 
population. In line with previous reviews, our study supports the validity of the 
WALT guidelines, which dictate that LLLT acts in a dose-dependent manner in 
tendinopathy. The external validity of Study I is primarily limited by the internal 
validity of the results, which originates from four different comparison groups, 
ranging between two and five studies for each comparison. A common critique of 
systematic reviews and meta-analysis is that they are not original research, as the data 
used for analyses originates from primary research studies. However, the originality 
of the research should be based on its novelty and usefulness rather than what appears 
as original or secondary research (Biondi-Zoccai et al., 2011).  
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In Study II, the subjects consist of 27 healthy young adults (22.5 years SD±2), 
comprising 54 healthy Achilles tendons. Skin and tendons degenerate with increasing 
age, and tendon pathology can produce changes in both morphology and biology. 
Hence, the generalization of the results from Study II to a heterogeneous population 
with tendon pathology has its limits.  
The use of animal models as surrogates for researching human health conditions has 
several shortcomings. The most obvious threat to external validity is the anatomical 
and physiological differences between species. There is no animal model that mimics 
human tendinopathy perfectly. The etiology and pathophysiology of tendinopathy is 
incompletely understood, which limits all animal models used for investigating 
aspects of human tendinopathy (Lui et al., 2011). Hence, the results of Study III 
should not be used to impose firm conclusions on human tendinopathy. One major 
advantage of using animal models is that the effect of an intervention can be 
measured at the tissue level as signs of accelerated healing or pathology 
improvement. The disadvantage is that pathology improvement cannot accurately be 
correlated with subjective outcomes such as pain relief, improved function, or quality 
of life. However, Study III provides evidence that cryotherapy can negatively 
influence the effect of LLLT in tendinopathy treatment, which can explain the lack of 
improvement in the study by Dogan et al. (2010).  
5.2.4 Statistics  
The meta-analysis in Study I was performed with RevMan (version 5.2), which is the 
software used in the Cochrane Database of Systematic Reviews. The validity of 
RevMan meta-analysis has been compared to analyses performed with several 
different commercial software programs, and no discrepancies in the results were 
reported (Bax et al., 2007). In Study II, Microsoft Excel 2011 was used for statistical 
analysis because of this software’s advantage in creating visualizations of the data 
sets. Some of the statistical functions of Microsoft Excel versions until 2007 have 
been criticized by statisticians, but these functions have been improved in later 
versions (Mélard, 2014). The p-values calculated from Microsoft Excel using 
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Student’s t-tests have been compared to SPSS analyses on similar data sets previously 
and found to be almost identical (Joensen, 2013). All statistical analyses of Study III 
were calculated on SPSS version 22. Non-parametric statistical methods were 
applied, as the data did not follow normal distribution. The Kruskal–Wallis analysis 
is adequate for detecting differences between several groups, but it will not indicate 
which groups are significantly different from each other. Consequently, multiple 
pairwise comparisons (Mann–Whitney U tests) had to be performed in Study III. We 
decided to compare the different treatment groups to one common reference group 
(ING), as the combination of cryotherapy and LLLT was a novel experimental 
treatment approach, and to limit the number of pairwise comparisons.  
5.2.5 Limitations of Studies I–III 
Study I 
Even though the overall effect for LLLT on pain and global improvement is 
encouraging in this review, the result should be interpreted with caution. The 
included trials were subjected to analysis in one out of four different comparison 
groups, depending on control group measures. Hence, the result for each comparison 
and outcome arises from a handful of studies. It should also be noted that our 
outcome measures are based solely on end-of-treatment data (2–12 weeks) and 
display the potential short-term effects of LLLT for shoulder tendinopathy. Only 
three trials (Al-Shenqiti and Oldham, 2003; Bal et al., 2009; Otadi et al., 2012) 
provided post-treatment follow-up data, and no robust conclusions can be drawn 
regarding the long-term effects. Synthesizing evidence was challenging for numerous 
reasons. In LLLT research, the validity of a study is based on both methodological 
quality and the validity of the intervention procedure. Clinical application procedures 
and laser parameters were poorly or inaccurately described in some studies (England 
et al., 1989; Logdberg-Andersson et al., 1997; Santamato et al., 2009; Abrisham 
et al., 2011). In addition, there were large variations in laser wavelength (nm), 
number of points treated, composition of co-interventions, and exercise design across 
the included studies. A lack of therapist blinding and an intention to treat analysis 
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were the two most frequent methodological shortcomings, consequently increasing 
the potential bias of this review. Although we thoroughly searched databases for 
available literature, hand-searches of the grey literature were not performed. As 
negative publication bias has been reported for the LLLT literature (Bjordal et al., 
2008), we cannot exclude the possibility that published trials may have been 
overlooked. 
Study II 
The use of a laser tripod and a hand-held OPM has its limitations. The exact amount 
of pressure exerted on the Achilles tendon from these devices was not measured. 
Although our experimental set up was identical for each measurement, we cannot 
exclude that small variations in Achilles squeezing occurred and influenced the 
outcome. The operator holding the OPM was blinded to all measurement recordings 
but could not be blinded to whether the tendon was cooled or not. We also observed a 
difference in MOP (no obstacle measurements) before and after ice for the 810 nm 
CW laser. Although this increase in MOP after ice was very small (1.6%), it was still 
significantly (p<0.01) higher than the before-ice measurements. However, a higher 
percentage of MOP-penetrating cooled Achilles were also found for the 810 nm CW 
laser, indicating that the increased penetration after ice cannot be explained by a 
higher MOP from the laser device alone. It should also be emphasized that our results 
originate from a homogenous population consisting of healthy young adults with a 
light skin tone. Dermal and tendinous tissue degenerates with increasing age 
(Lephart, 2016; Svensson et al., 2016) and can be influenced by both disease and 
activity levels (Wang, 2005; Kongsgaard et al., 2010; Babalola et al., 2014; Kjaer and 
Heinemeier, 2014). Careful consideration should be given before extrapolating the 
results of this study to a heterogeneous general population with pathology.  
Study III 
The experimental trauma model produced increased expression levels of pro- and 
anti-inflammatory cytokines, consistent with reactions known to occur in local 
inflammatory tendon disease (Kindt et al., 2007). It also caused a weakening of 
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tendon material, loss of stiffness, and loss of ability to withstand force before 
rupturing. These findings correlated well with the histopathological appearance of the 
tendons. Nevertheless, the use of animal models in tendinopathy research has several 
shortcomings. At present, there is no ideal model to induce tendinopathy in animals 
(Lui et al., 2011), and all of the models share the common limitation of an unclear 
pathophysiology in human tendinopathy (Rees et al., 2006). We decided to use the 
mini-guillotine model to mimic a tendon disorder with inflammatory components, 
which is comparable to early or acute tendinopathy (Millar et al., 2010). Achilles 
tendinopathy in humans is often associated with overuse, and it can develop over 
months or even years (Paavola et al., 2002). In vivo animal models, such as repeated 
uphill treadmill running, would better mimic the etiology of chronic human Achilles 
tendinopathy. However, it is also a more stressful procedure for the animals than our 
mini-guillotine model. We also found no evidence of its superiority in causing 
inflammatory reactions. Perhaps the most important limitation of this study is the 
absence of a functional outcome, as activity-related pain is a common clinical feature 
in human tendon disorders (Rio et al., 2014). This point should be emphasized, as 
histopathological changes and pain intensity do not necessarily correlate in humans 
(Magnan et al., 2014b). Consequently, the validity of our findings would be 
strengthened by indirect measures of pain such as the analysis of gait pattern (Lui 
et al., 2011). Our cytokine analysis also showed considerable variance, indicating that 
the sample size should be increased in future replica studies. In view of these 
shortcomings, careful consideration should be given before extrapolating the findings 




6. Conclusion  
The main purpose of this thesis was to investigate the clinical, biophysical, and 
biological effects of LLLT alone and in combination with cryotherapy for the 
treatment of tendinopathy. The hypothesis arose from our systematic review and 
meta-analysis (Study I), in which cryotherapy was identified as a possible negative 
confounding variable if administered parallel to LLLT in shoulder tendinopathy 
patients. This clinical finding revealed a gap in knowledge, stimulated our curiosity, 
and brought us to explore the potential biophysical and biological effects of 
combining LLLT and cryotherapy. The main insights from this thesis can be 
summarized as follows. 
In Study I, we demonstrated that LLLT acts in a dose-dependent manner in shoulder 
tendinopathy. Optimal LLLT can offer clinically relevant pain relief and initiate a 
more rapid course of improvement, both alone, in combination with exercises, and in 
combination with several physiotherapy interventions. However, the effects of 
optimal LLLT seemed to be inhibited if administered in combination with 
cryotherapy.  
In Study II, it was hypothesized that cryotherapy alters the biophysical penetration of 
LLLT. Consequently, we investigated the penetration of a CW 810 nm laser and an 
SPW 904 nm laser through skin and Achilles tendon in healthy humans, before and 
after 20 min of cryotherapy. LLLT penetration increased significantly through the 
Achilles area (skin-tendon-skin) for both lasers and at all measured time points, when 
skin surface temperature was lowered from 28.2˚C to 4.8˚C. This may indicate that 
cryotherapy can be used prior to LLLT to reach more deeply situated pathology but 
also that “over-dosing” the tendon with LLLT is possible if the biophysical effects of 
cryotherapy are limited to the skin.  
Finally, it was hypothesized that the combination of LLLT and cryotherapy would 
produce different biological responses in injured tendons when compared with no 
treatment or with LLLT or cryotherapy alone. Although we found that cryotherapy in 
combination with LLLT can produce an anti-inflammatory “add-on” effect in 
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Achilles tendinopathy of rats, other outcomes suggested that the order of therapy 
administration is essential to produce a beneficial biological effect in injured tendon 
tissue. Superior biomechanical and histology results were demonstrated if LLLT 
treatment followed cryotherapy. Conversely, cryotherapy after LLLT treatment 
produced the poorest biomechanical behavior and histological score of all treatment 
groups.  
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7. Perspectives  
This thesis has drawn attention to some interesting aspects regarding LLLT and 
cryotherapy in tendinopathy treatment. There are, however, several new questions to 
be answered: 
• To what extent do different cryotherapy modalities produce intra-tendinous 
temperature reductions in humans? 
• How is the infrared Class 3B laser’s ability to penetrate human skin and 
tendons after heat therapy? 
• What is the ideal timeframe for the initiation of LLLT and cryotherapy after 
tendon trauma in animals, and what are the optimal treatment parameters?  
• Is the ideal timeframe for the initiation of LLLT and cryotherapy different 
across different trauma models used to inflict tendon injury in animals?  
Most importantly, our findings clearly elucidate the need for future clinical RCTs that 
investigate whether cryotherapy in combination with LLLT can produce beneficial 
“add-on” effects in tendinopathy patients. As an extension of Study III, our research 
group is now recruiting Achilles tendinopathy patients to participate in a double-blind 
placebo-controlled RCT in which the effects of cryotherapy, LLLT, and exercise are 
compared to cryotherapy, placebo LLLT, and exercise. This ongoing clinical trial will 
also provide ultrasonography measurements of subcutaneous dermal tissue thickness 
and allow initial assessments of correlation between the depth to tissue target and 
magnitude of effect. 
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